先端医療シリーズ37　人工臓器・再生医療の最先端

出版社： 先端医療技術研究所
著者：
発行日： 2005-11-28
分野： 臨床医学：外科  >  移植/人工臓器
ISBN： 4925089455
電子書籍版： 2005-11-28 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

10,266 円(税込)

電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

5,133 円(税込)

購入する

商品紹介

本書は、先端医療シリーズ「21世紀への人工臓器」の続編であり、今回は特に人工臓器や再生医療に関する新しい概念や発見・発明あるいは国内外の最新の進歩の状況などを満載した。

目次

  • 先端医療シリーズ37　人工臓器・再生医療の最先端

    ―目次―

    第1章　人工心肺
    第2章　補助循環
    第3章　無拍動流補助人工心臓
    第4章　拍動流補助人工心臓
    第5章　全置換型人工心臓
    第6章　心不全に対する再生医療
    第7章　人工心臓弁
    第8章　人工血管と再生医療
    第9章　血管再生のための幹細胞生物学
    第10章　ペースメーカー・植え込み型除細動器
    第11章　呼吸器系
    第12章　泌尿器系
    第13章　消化器系
    第14章　運動器系
    第15章　皮膚
    第16章　感覚器その他
    第17章　人工臓器を支える要素技術
    第18章　再生医療の基盤技術
    第19章　臨床応用に向けた環境整備

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 人工心肺

P.3 掲載の参考文献
1) 西田 博ほか:第二次人工心肺革命と医工学的支援. 医工学治療13 (2):73-80, 2001
 
2) 西田 博ほか:限外ろ過機能を有する新しい膜型肺-"人工腎肺" の開発. 人工臓器23 (1):234-237, 1994
 
3) Nishida H, et al:Oxygenator with built-in hemoconcentrator:Anew concept. Artif Organs 19 (4):365-368, 1995
 
P.9 掲載の参考文献
1) Cosgrove DM, et al:Minimally invasive approach for aortic valve operations. Ann Thorac Surg 62:596-597, 1996
PubMed
2) Navia JL, et al:Minimally invasive mitral valve operations. Ann Thorac Surg 62:1542-1544, 1996
PubMed
3) 四津良平ほか:低侵襲小切開心臓手術 Minimally invasive cardiac surgery (MICS).川田志明編:体外循環と補助循環, 日本人工臓器学会セミナー, 日本人工臓器学会, p59-66, 1997
 
4) 四津良平ほか:内視鏡支援下僧帽弁手術-Videoassisted Mitral Valve surgery-. JSES 内視鏡外科 3:274-282, 1998
 
5) Schwartz DS, et al:Minimally invasive cardiopulmonary bypass with cardioplegic arrest. J Thorac Cardiovasc Surg 111:556-566, 1996
PubMed
6) Stevens JH, et al:Port-Access coronary artery bypass grafting. Ann Thorac Surg 62:435-441, 1996
PubMed
7) 又吉 徹ほか:低侵襲小切開心臓手術 (MICS) とその体外循環の工夫「体外循環」-落差脱血から吸引脱血へ-. 川田志明編:体外循環と補助循環, 日本人工臓器学会セミナー, 日本人工臓器学会,p65-76, 1999
 
8) Toomasian JM, et al:Extracorporeal circulation for Port-Access cardiac surjery. Perfusion 12:83-93, 1997
 
9) Peters WS, et al:Port-Access cardiac surgery. Perfusion 13:253-258, 1998
PubMed
10) Vanermen H, et al:Port-Access mitral valve surgery. Perfusion 13:249-252, 1998
PubMed
11) Gooris T, et al:perfusion techniques for Port-Access surgery. Perfusion 13:243-247, 1998
PubMed
12) Toonasian JM:Cardiopulmonary bypass for less Invasive procedures. Perfusion 14:279-286, 1999
 
13) Matayoshi T, et al:Development of a Completely Closed Circuit Using an Air Filter in a Drainage Circuit for Minimally Invasive Cardiac Surgery. Artificial Organs 24 (6):454-458, 2000
 
14) 又吉 徹ほか:体外循環低侵襲化への検討. 体外循環技術 30 (2):100-103, 2003
Medical*Online
P.15 掲載の参考文献
1) 百瀬直樹ほか:循環血液流量と循環血液量の調整を独立させた人工心肺. 人工臓器26 (23):605-609, 1997
 
2) 百瀬直樹ほか:人工肺における気泡除去能力の検定方法の考案-人工肺 Affinity BIOCOR CAPIOX-RXの気泡除去能力の評価-.体外循環技術28 No1:31-35, 2001
 
3) 百瀬直樹ほか:回路内圧によるローラーポンプの回転制御装置の開発. 人工臓器27 (2):409-412, 1998
 
4) Momose N, et al:Anew cardiopulmonary bypass operating system enabling surgeon`s regulation in operation field. Journal of Artificial Organs 4:278-282, 2001
 

第2章 補助循環

P.20 掲載の参考文献
1) Frazier OH, et al:Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg 222:327-338, 1995
PubMed
2) Frazier OH, et al:Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg 57:1416-1422, 1994
PubMed
3) Nishimura M, et al:A successful bridge to resynchronization therapy with a left ventricular assist system in a patient with idiopathic dilated cardiomyopathy. J Artif Organ 8:210-213, 2005
 
4) Frazier OH, et al:Use of Flowmaker (Jarvik 2000) left ventricular assist device for destination therapy and bridging to transplantation. Cardiology 101:111-116, 2004
PubMed
5) Deng MC, et al:Mechanical circulatory support device database of the international society for heart and lung transplantation:second annual report-2004. J Heart Lung Transplant 23:1027-1034, 2004
PubMed
P.26 掲載の参考文献
1) 岡田昌義ほか編:21世紀への人工臓器, 先端医療技術研究所, 東京, p16-29, 1998
 
2) 荒井裕国:大動脈内バルーンパンピングーテクノロジーの進歩と今後の展望-. 体外循環技術 31 (2):121-132, 2004
 
3) Nishida H, et al:Comparative study of five types of IABP balloons in terms of incidence of balloon rupture and other complications:amulti-institutional study. Artificial Organs 18 (10):746-751, 1994
 
4) Cohen M, et al:Comparison of Outcomes After 8 vs. 9.5 French Size intra-Aortic Balloon Counterpulsation Catheters Based on 9,332 Patients in the Prospective benchmark Registry. Cathet Cardiovasc Intervent 56:200-206, 2002
 
5) Swartz MT, et al:Effects of Intraaortic Balloon Position on Renal Artery Blood Flow. Ann Thorac Surg 53:604-610, 1992
PubMed
6) 吉岡幸男ほか:日本人の体格に適したIABPバルーンサイズの検討. 胸部外科 40 (9):736-742, 1987
 
7) Bolooki H:Clinical Application of the Intra-Aortic Balloon Pump, Third revised Edition, Futura, New York, 1998
 
P.31 掲載の参考文献
1) 宮本裕治ほか:本邦における経皮的心肺補助療法の使用状況-全国集計報告-. ICUとCCU 181:939. 943, 1994
 
2) 松田 暉ほか:ECMO臨床使用の状況と展望. 人工臓器 1992, 中山書店, 東京, p154-163, 1992
 
3) Hill JD, et al:Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (Shock-lungsyndrome). N Eng J Med 286:629-634, 1972
 
4) Zapol WM, et al:Extracor-poreal mambrane oxygenation in severe acute respiratory failure. JAMA 42:2193-2196, 1979
 
5) Phillips SJ, et al:Percutaneous cardiopulmonary bypass, Applicationan dindication foruse. Ann Thorac Surg 47:121-123, 1989
 
6) Reichman RT, et al:Improved patient survival after cardiac arrest using a cardiopulmonary support system. Ann Thorac Surg 49:101-105, 1990
PubMed
7) Phillips SJ, et al:Percmaneous mitiation of cardiopulmonaly bypass. Ann Thorac Surg 36:223-225, 1983
 
8) Vogel RA, et al:Initial experience with coronary angioplasty and aortic valvuloplasty using elective semipercutaneous cardiopulmonaly support. Am J Cardiol 62:811-813, 1988
 
P.34 掲載の参考文献
1) lmpella CardioSystems 社ホームページ http://www.impella.com/
 
2) Meyns B, et al:Left ventriculat support by catheter-mounted axial flow pump reduces infarct size. J Am Coll Cardiol 41:1087-1095, 2003
 
3) Jurmann MJ, et al:Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg 77:1642-1647, 2004
PubMed
4) Meyns B, et al:Coronary artery bypass grafting supported with intracardiac microaxial pumps versus normothermic cardiopulmary bypass:a prospective randomized trial. Eur J Cardio-thoraci Surg 22:112-117, 2002
 
5) Siess T, et al:Concept, Realization, and First In Vitro Testing of an Intraarterial Microaxial Blood Pump. Artif Organs 19:644-652, 1995
 

第3章 無拍動流補助人工心臓

P.39 掲載の参考文献
1) Boughque K, et al:In vitro assessment of Rotary LVAD induced artificial pulse. Asaio J 51 (2):21A, 2005
 
2) Micro Med Technology lnc http://www.micromedtech.com/
 
3) (株)サンメディカル技術研究所 http://www.evaheart.co.jp/
 
4) Berlin Heart AG http://www.berlinheart.com/
 
5) Terumo http://www.terumo.co.jp/press/index.html
 
6) Ventracor Limited http://www.ventracor.com/default.asp
 
7) Duncan BW, et al:The PediPump:a new ventricular assist device for children. Artif Organs 29 (7):527-530, 2005
PubMed
8) First International Conference on Pediatric Mechanical Circulatory Support Systems and Pediatric Cardiopulmonaly Perfusion, Conference Proceedings;Hotel Hershey, Pennsylvania USA, p43-48, 2005
 
9) Jarvik R, et al:Initial Results with the Pediatric Jarvik 2000 Heart. Asaio J 51 (2):29A, 2005
 
10) Pantalos GM, et al:Initial In Vitro Performance Results for the 4"and 3"PCAS Pediatric Assist Device. Asaio J 51 (2):37A, 2005
 
11) Weiss WJ, et al:Development of a Pulsatile Ventricular Assist Device for lnfants and Children. Asaio J 51 (2):28A, 2005
 
12) Wu J, et al:Elimination of Reversal Flow in Back Clearance Gaps of a Miniature Pediatric Centrifugal blood Pump by CFD. Asaio J 51 (2):40A, 2005
 
13) JarVik Heart lnc http://wwwjarvikheart.com/home.asp
 
14) Morales DLS, et al:The DeBakey VAD Child:First Implantable Ventricular Assist Device for Children in the United States (Finally, The Child Gets Attention!) Pediatric Cardiology Today 2 (6):2004 www.pediatric.cardiology.today.com
 
15) Patel SM, et al:A Reliability Model for a Ventricular Assist Device. Asaio J 51 (2):21A, 2005
 
P.42 掲載の参考文献
1) Kherani AR, et al:Ventricular assist devices as a bridge to transplant or recovery. Cardiology 101:93-103, 2004
 
2) Rose EA, et al:Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure.
 
3) Raman J, et al:Destination therapy with ventricular assist devices. Cardiology 101:104-110, 2004
PubMed
4) Frazier OH, et al:Use of the Flowmaker (Jarvik 2000) left ventricular assist device for destination therapy and bridging to transplantation. Cardiology 101:111-116, 2004
PubMed
5) Frazier OH, et al:Clinical experience with an implantable, intracardiac, continuous flow circulatory support device:physiologic implications and their relationship to patient selection. Ann 105:2855-2860, 2002
 
6) Frazier OH, et al:Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation 105:2855-2860, 2002
PubMed
7) Siegenthaler MP, et al:The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device. Eur J Cardiothorac Surg 23:748-754, 2003
 
8) Tuzun E, et al:The effect of intermittent low speed mode upon aortic valve opening in calves supported with a Jarvik 2000 axial flow device. ASAIO J 51:139-143, 2005
PubMed
9) Goldstein DJ:Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation. Circulation 108 (Suppl 1):II 272-277, 2003
 
10) Frazier OH, et al:First clinical use of the redesigned HeartMate II left ventricular assist system in the United States:a case report. Tex Heart lnst J 31:157-159, 2004
 
11) Record of Clinical Trials. gov by U. S. National Institute of Health:Thoratec HeartMate II left ventricular assist syste (LVAS) for destination therapy.
 
12) Hetzer R, et al:First experiences with a novel magnetically suspended axial flow left ventricular assist device. Eur J Cardiothorac Surg 25:964-970, 2004
PubMed
P.47 掲載の参考文献
1) Rose EA, et al:Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345:1435-1443, 2001
PubMed
2) Akmatsu T, et al:Centrifugal pump with a magnetically suspended impeller Artif Organs 16:305-308, 1992
 
3) Nojiri C, et al:Terumo implantable left ventricular assist system (T-ILVAS) Results of long-term animal study. ASAIO J 46:117-122, 2000
 
4) Saito S, et al:Reliable long-term non-pulsatile circulatory support without anticoagulation. Eur J Cardiothorac Surg 19:678-683, 2001
 
5) Saito S, et al:End-organ function during chronic nonpulsatile cirvulation. Ann Thorac Surg 74:1080-1085, 2002
PubMed
P.51 掲載の参考文献
1) Stevenson LW:Clinical use of inotropic therapy for heart failure:looking backward or forward? Circulation 108:492-497, 2003
 
2) Rose EA, et al:Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345:1435-1443, 2001
PubMed
3) Yamazaki K, et al:EVAHEART:An implantable centrifugal blood pump for long-term circulatory support. Jap J Thorac Cardiovasc Surg 50:461-465, 2002
 
4) Yamazaki K, et al:An implantable centrifugal blood pump with a recirculating Purge system (Cool-Seal system). Artificial Organs 22 (6):466-474, 1998
PubMed
P.57 掲載の参考文献
1) Nose Y:Design and development strategy for the rotary blood pump. Artif Organs 22 (6):438-446, 1998
PubMed
2) Goldstein DJ, et al:Safety and feasibility trial of the MicroMed DeBakey ventricular assist device as a bridge to transplantation. J Am Coll Cardiol 45 (6):962-963, 2005
PubMed
3) Yamazaki K, et al:EVAHEART:an implantable centrifugal blood pump for long-teml circulatory support. Jpn J Thorac Cardiovasc Surg 50 (11):461-465, 2002
 
4) Takatani S, et al:Mechanical circulatory support devices (MCSD) in Japan:current status and future directions. J Artif Organs 8 (1):13-27, 2005
PubMed
5) Nose Y, et al:Therapeutic and physiological artificial heart:future prospects. Artif Organs 21 (7):592-596, 1997
PubMed
6) Furukawa K, et al:Right ventricular failure after left ventricular assist device implantation:the need for an implantable right ventricular assist device. Artif Organs 29 (5):369-377, 2005
PubMed
7) Yoshikawa M, et al:Development of the NEDO implantable ventricular assist device with Gyro centrifugal pump. Artif Organs 24 (6):459-467, 2000
PubMed
8) Ichikawa S, et al:In vivo evaluation of the NEDO biventricular assist device with an RPM dynamic impeller suspension system. ASAIO J 49 (5):578-582, 2003
PubMed
9) Ohtsuka G, et al:Long-term in vivo left ventricular assist device study with a titanium centrifugal pump. ASAIO J 44 (5):M619-623, 1998
PubMed
10) Kawahito S, et al:Long-term ex vivo bovine experiments with the Gyro C1E3 centrifugal blood pump. ASAIO J 49 (1):112-116, 2003
PubMed
11) Yamane T, et al:Flow visualization in a centrifugal blood pump with an eccentric inlet port. Artif Organs 28 (6):564-570, 2004
 
12) Standard Practice for Assessment of Hemolysis in Continuous Flow Blood Pumps, 2005, American Standard for Testing and Materials. F1841-1897, 2005
 
13) Altieri F, et al:Long-term mechanical circulatory support system reliability recommendation:American Society for Artificial lntemal Organs and Society of Thoracic Surgeons:long-term mechanical circulatory support system reliability recommendation. ASAIO J 44 (1):108-114, 1998
PubMed

第4章 拍動流補助人工心臓

P.63 掲載の参考文献
1) Kyo S, et al:Ventricular assist system. Kyobu Geka 56 (1):61-70, 2003
PubMed
2) Navia JL, et al:Do left ventricular assist device (LVAD) bridge-to-transplantation outcomes predict the results of permanent LVAD implantation? Ann Thorac Surg 74 (6):2051-2062, 2002
PubMed
3) Rose EA, et al:Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345:1435-1443, 2001
PubMed
4) El-Banayosy A, et al:Preliminary experience with the LionHeart left ventricular assist device in patients with end-stage heart failure. Ann Thorac Surg 75 (5):1469-1475, 2003
PubMed
5) Drews TN, et al:Outpatients on mechanical circulatory support. Ann Thorac Surg 75 (3):780-785, 2003
PubMed
6) Cooley DA, et al:First human implantation of a cardiac prosthesis for staged total replacement of the heart. Trans Am Soc Artif lntern Organs 15:252, 1969
 
7) Copeland JG, et al:The total artificial heart as a bridge to transplantation:A report of two cases. JAMA 256:2991, 1986
PubMed
8) Norman JC, et al:Total support of the circulation of a patient with post-cardiotomy stone-heart syndrome by a partial artificial heart (ALVAD) for five days followed by heart and kidney transplantation. Lancet 1:1125, 1978
 
9) Long JW:Advanced mechanical circulatory support with the HeartMate left ventricular assist device in the year 2000. Ann Thorac Surg 71 (3 Suppl):S176-182;discussion S183-184, 2001
 
10) Copeland JG:Multicenter bridge to transplantation with the HeartMate assist device:evaluation from another perspective. J Thorac Cardiovasc Surg 125 (2):228-230, 2003
PubMed
11) Frazier OH:Multicenter bridge to transplantation with the HeartMate assist device:evaluation from another perspective, A rebuttal. J Thorac Cardiovasc Su]rg l 25 (2):440-441, 2003
 
12) Portner PM, et al:Improved outcomes with an implantable left ventricular assist system:a multicenter study. Ann Thorac Surg 71 (1):205-209, 2001
PubMed
13) Robbins RC, et al:The totally implantable novacor left ventricular assist system. Ann Thorac Surg 71 (3 Suppl):S162-165;discussion S183-184, 2001
 
14) Casarotto D, et al:The last to die is hope:prolonged mechanical circulatory support with a Novacor left ventricular assist device as a bridge to transplantation. J Thorac Cardiovasc Surg 125 (2):417-418, 2003
PubMed
15) 許俊鋭:ノバコア保険償還の経緯と今後の課題.Cardio-vascular Med-Surg 7 (2):2004
 
16) Omoto R, et al:Japanese multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system. J Artif Organs 8 (1):34-40, 2005
PubMed
17) Rose EA, et al:Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345:1435-1443, 2001
PubMed
18) Wieselthaler GM, et al:First experiences with outpatient care of patients with implanted axial flow pumps. Artif Organs 25 (5):331-335, 2001
PubMed
19) Vitali E, et al:Successful experience in bridging patients to heart transplantation with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg 75 (4):1200-1204, 2003
PubMed
20) Burke DJ, et al:The Heartmate II:design and development of a fully sealed axial flow left ventricular assist system. Artif Organs 25 (5):380-385, 2001
PubMed
21) Frazier OH, et al:Initial clinical experience with the Jarvik 2000implantable axial-flow left ventricular assist system. Circulation 105 (24):2855-2860, 2002
PubMed
22) Westaby S, et al:Postauricular percutaneous power delivery for permanent mechanical circulatory support. J Thorac Cardiovasc Surg 123 (5):977-983, 2002
PubMed
23) Frazier OH:Implantation of the Jarvik 2000 left ventricular assist device without the use of cardiopulmonary bypass. Ann Thorac Surg 75 (3):1028-1030, 2003
PubMed
24) Saito S, et al:Reliable long-term non-pulsatile circulatory support without anticoagulation. Eur J Cardiothorac Surg 19 (5):678-683, 2001
 
25) Yamazaki K, et al:EVAHEART:an implantable centrifugal blood pump for long-term circulatory support. Jpn J Thorac Cardiovasc Surg 50 (11):461-465, 2002
PubMed
P.68 掲載の参考文献
1) 中谷武嗣:治療の進歩:補助人工心臓. 日本内科学会雑誌 94:111-118, 2005
 
2) Takano H, et al:Ventricular assist systems:Experience in Japan with Toyobo pump and Zeon Pump. Ann Thorac Surg 61:317-322, 1996
PubMed
3) Nakatani T, et al:Development and in Vivo evaluation of implantable left ventricular assist system with an impedance based monitoring and control system. ASAIO J 41:M324-M327, 1995
PubMed
4) 中谷武嗣ほか:左室心尖脱血方式左心補助人工心臓の臨床例の検討. 人工臓器29:S39, 2000
 
5) 慢性心不全治療ガイドライン. Jpn Circ J 64 (Suppl 4):1023-1079, 2000
 
6) 中谷武嗣:日本における心臓移植の現況.今日の移植18:287-293, 2005
 
7) Rose EA, et al:Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345:1435-1443, 2001
PubMed
P.73 掲載の参考文献
1) Tayama E, et al:A Virtual Experience of Long-distance Transportation of Patients With a Paracorporeal Left Ventricular Assist System. J Artif Organs 3:62-69, 2000
 
2) Nishinaka T, et al:Development of an ultra-compact and low-noise portable driver for pneumatic ventricular assist devices. ASAIO J 47:117, 2001
 
3) 西中知博ほか:国産空気圧駆動式補助人工心臓用の携帯型駆動装置の開発. 人工臓器29:S13, 2000
 
4) 西中知博ほか:小型, 軽量, 低電力消費, かつ音が静かな国産空気圧駆動式補助人工心臓用携帯型駆動装置の開発. 人工蔵器30:S36, 2001
 
5) Nishinaka T, et al:Ventricular assist device treated with newly developed biocompatible coating material and compact and low-noise pneumatic portable driver. Int J of Artif Organs 25:670, 2002
 
6) 西中知博ほか:血液適合化医用材料表面処理技術と軽量小型駆動装置の開発による国立循環器病センター型補助人工心臓システムの改良.Jpn J Thorac Cardiovasc Surg 50:210, 2002
 
7) 西中知博ほか:補助人工心臓装着患者の安全性とQOLの向上を目指した空気駆動式補助人工心臓用携帯型小型駆動装置モバートNCVCの開発. 循環器病研究の進歩 24:67-73, 2003
 

第5章 全置換型人工心臓

P.78 掲載の参考文献
1) Dowling RD, et al:The AbioCor implantable replacement heart. Ann Thorac Surg 75 (6 suppl):S93-99, 2003
 
2) Dowling RD, et al:Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 127:131-141, 2004
PubMed
3) Frazier OH, et al:The total artificial heart:where we stand. Cardiology 101:117-121, 2004
PubMed
4) Copeland JG, et al:Cardiac replacement with atotal artificial heart as a bridge to transplantation. N Eng J Med 351:859-867, 2004
 
5) El-Banayosy A, et al:CardioWest Total Artificial Heart:Bad Oeynhausen Experience. Ann Thorac Surg 80:548-552, 2005
PubMed
P.84 掲載の参考文献
1) Masuzawa T, er al:Progress of an electrohydraulic total artificial heart system with a separate energy converter. ASAIO J 45:471-477, 1999
 
2) Tatsumi E, et al:Current status of development and in vivo evaluation of the National Cardiovascular Center electrohydraulic total artificial heart system. J Artif Organs 3:62-69, 2000
 
3) Tatsumi E, et al:The National Cardiovascular Center electrohydraulic total artificial heart and ventricular assist device Systems:Current Status of Development. ASAIO Journal 49:243-249, 2003
PubMed
4) Homma A, et al:Current status of the National Cardiovascular Center totally implantable artificial heart system. SICE Annual Conference 2004 in Sapporo:436-441, 2004
 
5) Homma A, et all In vivo evaluation of the National Cardiovascular Center electrohydraulic totally implantable artificial heart and ventricular assist device systems. ASAIO J 51:31A, 2005
 
6) Lee HS, et al:Measurement of the closing behavior of the Bjork-shiley monoleaflet mechanical heart valve with an electrohydraulic total artificial heart. Artif Organs 27 (8):744-748, 2003
 
7) Taenaka Y, et al:Dimensional criteria for totally implantable artificial hearts for human use. Artif Organs 14:83-86, 1990
 
8) Zhang B, et al:Noninvasive assessment method to determine the anatomic compatibility of an implantable artificial heart system. ASAIO J 46:590-595, 2000
PubMed
9) Honda H, et al:Selection of a rechargeable internal back-up battery for a totally implantable artificial heart. ASAIO J 45:339-343, 1999
PubMed
10) Shiba K, et al:A transcutaneous energy transmission system rechargeable internal back-up battery for a totally implantable total artificial heart. ASAIO J 45:466-470, 1999
PubMed
11) Kakuta Y, et al:In Vivo long term evaluation of transcutaneous energy transmission for totally implantable artificial heart. ASAIO J 46 (2):170, 2000
 
12) Inoue K. et al:Transcutaneous optical telemetry system with infrared Laser Diode. ASAIO J 44:841-844, 1998
PubMed
13) Tatsumi E, et al:A blood pump with an interatrial shunt for use as an electrohydraulic total artificial heart. ASAIO J 38:M425-430, 1992
PubMed
14) Tatsumi E, et al:In vitro and in vivo evaluation of a left-right balancing capacity of an interatrial shunt in an electrohydraulic total artificial heart system. ASAIO J 43:M619-625, 1997
 
15) Amemiya S, et al:Computer simulation to determine the anatomic compatibility of implantable artificial organs. Transaction of the Japanese Society for Medical and Biological Engineering 43 (Suppl 1):519, 2005
 
P.89 掲載の参考文献
1) Akutsu T, et al:Permanent substitutes for valves and hearts. Trans Am Soc Artif Intem Organs 4:230, 1957
 
2) Copeland JG, et al:Total artificial heart:bridge to transplantation. Cardiol Clin 21 (1):101-113, 2003
PubMed
3) Cooley DA:The total artificial heart. Nature Medicine 9:108-111, 2003
PubMed
4) Samuels L, et al:Use of the AbioCor replacement heart as destination therapy for end-stage heart failure with irreversible pulmonary hypertension. J Thorac Cardiovasc Surg 128 (4):643-645, 2004
PubMed
5) Copeland JG:Current status and future directions for a total artificial heart with a past. Artif Organs 22 (11):998-1001, 1998
PubMed
6) Takatani S, et al:One piece ultracompact totany implantable electromechanical total artificial heart for permanent use. ASAIO J 48:538-545, 2002
PubMed
7) Takatani S, et al:Mechanical circulatory support devices for bridge to heart transplantation, bridge to recovery, or destination therapy. J Artif Organs 3:75-84, 2000
PubMed
8) 岩脇健治ほか:人工心臓用コア. 型経皮トランスの開発. 人工臓器33 (2):S199, 2004
 
9) Honda N, et al:Ultracompact, completely implantable permanent use electromechanical ventricular assist device and total artificial heart. Artif Organs 23 (3):253-261, 1999
PubMed
10) Takatani S, et al:Development of a totally implantable electromechanical total artificial heart:Baylor TAH. Artif Organs 16 (4):398-406, 1992
PubMed
11) Takatani S, et al:Left and right pump output control in one-piece electromechanical total artificial heart. Artif Organs 17 (3):176-184, 1993
PubMed
12) Takatani S, et al:A miniature hybrid reflection type optical sensor for measurement of hemoglobin content and oxygen saturation of whole blood. IEEE Trans Biomed Eng 35:187-198, 1988
PubMed
13) Shiono M, et al:Anatomic constraints for a total artificial heart in orthotopic heart transplant recipients. J Heart Lung Transplant 13 (2):250-262, 1994
PubMed
14) Kobayashi E, et al:Mechanical properties and corrosion resistance of Ti-6Al-7Nb alloy dental casting. J Mater Sci Mater Med 9 (10):567-574, 1998
PubMed
15) Iwasaki Y, et al:The effect of the chemical structure of the phospholipid polymer on fibronectin adsorption and fibroblast adhesion on the gradient phospholipid surface. Biomaterials 20:2185-2191, 1999
PubMed
16) Iwasaki Y, et al:Semi-interpenetrating polymer networks composed of biocompatible phospholipids polymer and segmented polyurethane. J Biomed Mater Res 52 (4):701-708, 2000
 
17) Morimoto N, et al:Physical properties and blood compatibility of suface-modified segmented polyurethane by semi-interpenetrating polymer networks with a phospholipids polymer. Biomaterials 23:4881-4887, 2002
 
18) Kobayashi K, et al:The segmented polyurethane modified by photopolymerization and cross-linking with 2-Methacryloy-loxyethyl phosphorylcholine polymer for blood contacting surface of the ventricular assist devices. J Artif Organs (in press)
 
P.94 掲載の参考文献
1) Abe Y, et al:Over 500 Days Survival of a Total Artificial Heart Goat with 1/R Control. Akutsu T, Koyanagi H, ed:Heart Replacement-Artificial Heart 6, Springer-Verlag, Tokyo, p34-40, 1998
 
2) Abe Y, et al:Development of the undulation pump total artificial heart. Artificial Organs 21 (7):665-669, 1997
PubMed
3) Abe Y, et al:Implantation of the undulation pump total artificial heart in the goat. Artificial Organs 23 (10):932-938, 1999
PubMed
4) Abe Y, et al:Third model of the undulation pump total artificial heart. ASAIO Journal 49:123-127, 2003
PubMed
5) Imachi K, et al:The jellyfish valve:a polymer membrane valve for the artificial heart. Akutsu T, Koyanagi H, ed:Heart Replacement:Artificial Heart 4, Springer-Verlag, Tokyo, p41-44, 1993
 
6) Abe Y, et al:Physiological Control of a Total Artificial Heart:Conductance-and Arterial Pressure-based Control J Appl Physiol 84 (3):868-876, 1998
PubMed

第6章 心不全に対する再生医療

P.99 掲載の参考文献
1) Melo LG, et al:Gene and cell-based therapies for heart disease. FASEB J 18:648-663, 2004
PubMed
2) Reinlib L, et al:Cell transplantation as future therapy for cardiovascular disease?: A workshop of the National Heart, Lung, and Blood Institute. Circulation 101:E182-187, 2000
PubMed
3) Nugent HM et al:Tissue engineering therapy for cardiovascular disease. Circ Res 92:1068-1078, 2003
PubMed
4) Laflamme MA, et al:Regenerating the heart. Nat Biotechnol 23:845-856, 2005
PubMed
5) Zandonella C, et al:Tissue engineering:The beat goes on. Nature 421:884-886, 2003
PubMed
6) Cohen S, et al:Rebuilding broken hearts. Biologists and engineers working together in the fledgling field of tissue engineering are within reach of one of their greatest goals:constructing a living human heart patch. Sci Am 291:44-51, 2004
PubMed
7) Shimizu T, et al:Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 24:2309-2316, 2003
PubMed
8) Shimizu T, et al:Electrically communicating three-dimensional cardiac tissue mimic fabricated by layered cultured cardiomyocyte sheets. J Biomed Mater Res 60:110-117, 2002
 
9) Shimizu T, et al:Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90:e40-48, 2002
PubMed
10) Kofidis T, et al:Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J Thorac Cardiovasc Surg 128:571-578, 2004
PubMed
P.104 掲載の参考文献
1) Miyagawa S, et al:Myocardial regeneration therapy for heart failure:hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation 105 (21):2556-2561, 2002
PubMed
2) Funatsu T, et al:Therapeutic angiogenesis induced by myocardial injection of naked cDNA plasmid encoding hepatocyte growth factor in ischemic canine heart. J Thorac Cardiovasc Surg 124 (6):1099-1105, 2002
 
3) Kondo H, et al:Re-organization of cytoskeletal proteins amd prolonged life expectancy caused by hapatocyte growth factor in a hamster model of late-phase dilated cardiomyopathy. J Thorac Cardiovasc Surg (in press)
 
4) Memon IA, et al:A combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in the canine hearts for ischemic cardiomyopathy. J Thorac Cardiovasc Surg 130:646-653, 2005
PubMed
P.108 掲載の参考文献
1) Huikeshoven M, et al:35 years of experimental research in transmyocardial revascularization:what have we learned? Ann Thorac Surg 74:956-970, 2002
PubMed
2) Stone GW, et al:A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions. J Am Coll Cardiol 39:1581-1587, 2002
PubMed
3) Nishida T, et al:Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 110:3055-3061, 2004
PubMed
4) Schumacher B, et al:Induction of neoangiogenesis in ischemic myocardium by human growth factors:first clinical results of a new treatment of coronary heart disease. Circulation 97:645-650, 1998
PubMed
5) Losordo DW, et al:Gene therapy for myocardial angiogenesis:initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98:2800-2804, 1998
PubMed
6) Kastrup J, et al:Direct intramyocardial plasmid vascular endothelial growth factor-A 165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study:the Euroinject One trial. J Am Coll Cardiol 45:982-988, 2005
 
7) Asahara T, et al:Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967, 1997
PubMed
8) Hamano K, et al:Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease:clinical trial and preliminary results. Jpn Circ J 65:845-847, 2001
PubMed
9) Heeschen C, et al:Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109:1615-1622, 2004
PubMed
10) Iwaguro H, et al:Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105:732-738, 2002
PubMed
11) Li TS, et al:Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. Am J Physiol Heart Circ Physiol 283:H468-473, 2002
PubMed

第7章 人工心臓弁

P.114 掲載の参考文献
1) Rahimtoola SH, et al:Choice of prosthetic heart valve for adult patiens. J Am Coll Cardiol 41:893-904, 2003
 
2) Potter DD, et al:Operative risk of reoperative aortic valve replacement. J Thorac Cardiovasc Surg 129:94-103, 2005
PubMed
3) Melina G, et al:Electron beam tomography for the cusp calcification in homograft versus freestyle xenograft. Ann Thorac Surg 71:S368-370, 2001
 
4) Bach DS, et al:Ten-year outcome after aortic valve replacement with the freestyle stentless bioprosthesis. Ann Thorac Surg 80:480-487, 2005
PubMed
5) Kon ND, et al:Eight-year results of aortic root replacement with the Freestyle stentless porcine aortic root bioprosthesis. Ann Thorac Surg 73:1817-1821, 2002
PubMed
6) Jin XY, et al:Performance of Edwards Prima stentless aortic valve over eight years. Semin Thorac Cardiovasc Surg 13:163-167, 2001
PubMed
7) Westaby S, et al:Valve replacement with a stentless bioprosthesis:versality of the porcine aortic root. J Thorac Cardiovasc Surg 116:477-484, 1998
 
8) Walther T, et al:Regression of left ventricular hypertrophy after stentless versus conventional aortic valve replacement. Semin Thorac Cardiovasc Surg 11 (Suppl 1):18-21, 1999
 
9) David TE, et al:Aortic valve replacement with stentless and stented porcine valve:a case-match study. J Thorac Cardiovasc Surg 116:236-241, 1998
 
10) Westaby S, et al:Survival advantage of stentless aortic bioprosthesis, Ann Thorac Surg 70:785-791, 2000
PubMed
11) Grunkemeier GL, et al:Long-term perfomance of heart valve prosthesis. Curr Probl Cardiol 25:73-156, 2000
 
12) Edwards Lifesciences:Clinical communique 20 year results Carpentier-Edwards PERIMOUNT aortic pericardial bioprosthesis &16 year results Carpentier-Edwards PERIMOUNT mitral pericardial bioprosthesis
 
13) Medtronic:Mosaic aortic and mitral bioprosthesis:eight year clinical compendium
 
14) Deeb GM, et al:Reoperation for Freestyle stentless aortic valves. Semin Thorac Cardiovasc Surg 13:16-23, 2001
PubMed
15) David TE, et al:Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg 121:268-278, 2001
PubMed
P.117 掲載の参考文献
1) O'Brien MF, et al:A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg 94:812-823, 1987
 
2) Gunning A:Comments on Ross' first homograft replacement of the aortic valve (letter to the editor). Ann Thorac Surg 54:809-810, 1992
 
3) O'Brien MF, et al:The homograft aortic valve:a 29-year, 99.3% follow up of 1022 valve replacements. J Heart Valve Dis 10:334-344, 2001
 
4) Schoen FJ:Approach to the analysis of cardiac valve prostheses as surgical pathology or autopsy specimens. Cardiovasc Pathol 4:241-255, 1995
PubMed
5) Ketheesan, et al:The effect of cryopreservation on the immunogenicity of allogeneic valves. Cryobiology 33:41-53, 1996
PubMed
6) Ferrans VJ, et al:Structural changes in glutarraldehyde-treated porcine heterografts used as substitute cardiac valves. Am J Cardiology 41:1159-1184, 1978
 
7) IIoekstra F, et al:Effect of cryopreservation and IILA-DR matching on the cellular immunogenicity of human cardiac valve allografts. J Heart Lung Transplant 13:1095-1098, 1944
 
8) O'Brien MF, et al:Cryopreserved viable allograft aortic valve, Yankah AC, ed:Cardiac valve Allograft 1962-1987. Springer-Verlag, NY, p311-321, 1987
 
9) Tweddell SJ, et al:Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation 102:III 130-135, 2000
 
10) Murakami A, et al:Saphenous vein homograft containing a valve as a right ventricle-pulmonary artery conduit in the modified Norwood operation. J Thorac Cardiovasc Surg 124:1041, 2002
PubMed
11) Yankah AC, et al:Surgical management of acute aortic root endocarditis with viable homograft:13-year experience. Eur J Cardio thorac Surg 21:260-267, 2002
 
12) Knosalla C, et al:Surgical treatment of active infective aortic valve endocarditis with associated perannular abscess-11 year results. Eur Heart J 21:490-497, 2000
 
13) Sabik JF, et al:Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg 74:650-659, 2002
PubMed
14) Fullerton DA, et al:The Ross procedure in adults:intermediate-term results. Ann Thorac Surg 76:471-477, 2003
PubMed
15) Ali M, et al:Homograft replacement of the mitral valve:eight-year results. J Thorac Cardiovasc Surg 128:529-534, 2004
PubMed
16) Kumar AS, et al:Homograft mitral valve replacement:five years:results. J Thorac Cardiovasc Surg 120:450-458, 2000
PubMed
P.121 掲載の参考文献
1) Shin'oka T, et al:Midterm clinical results of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 129:1330-1338, 2005
 
2) Hibino N, et al:Long-term histologic findings in pilmorary ar:teries reconstructed with autologous pericardium. N Engl J Med 348 (9):865-867, 2003
 
3) Matsumura G, et al:Successful Application of Tissue Engineered Vascular Autografts;Clinical Experience. Biomaterial 24:2303-2308, 2003
 
4) Matsumura G, et al:First Evidence That Bone Marrow Cells Contribute to the Construction of Tissue-Engineered Vascular Autografts In Vivo. Circulation 108:1729-1734, 2003
 
5) Isomatsu Y, et al:Extracardiac total cavopulmonary connection using a tissue-engineered graft. J Thorac Cardiovasc Surg X 126:1958-1962, 2003
 
6) Shinoka T:Tissue Engineered Heart Valves:Autologous Cell Seeding on Biodegradable Polymer Scaffold Artificial. Organ 26:522-526, 2002
 
7) Naito Y, et al:A Successful Clinical Application of Tissue Engineered Graft for Extracardiac Fontan Operation. Thoracic Cardiovasc Surg 125:416-420, 2002
 
8) Shinoka T, et al:Transplantation of a tissue-engineered pulmonary artery. N Engl Med 344:532-533, 2001
PubMed
9) Watanabe M, et al:Tissue engineered vascular autograft-inferior vena cava replacement in a dog model-. Tissue Engineering 7:429-439, 2001
 
10) Shinoka T, et al:Current Status of Tissue Engineering for Cardiovascular Structure. J Artif Organ 3:102-126, 2000
 
11) McKay R:Stem cells-hype and hope. Nature 406:361-364, 2000
PubMed
12) Shinoka T, et al:Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 115:536-546, 1998
PubMed
13) Shinoka T, et al:Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation 94:II 164-168, 1996
 
14) Noishiki Y, et al:Autocrine angiogenic vascular prosthesis with bone marrow transplantation. Nat Med 2:90-93, 1996
PubMed
15) Shinoka T, et al:Tissue engineering heart valves:valve leaflet replacement study in a lamb model. Ann Thorac Surg 60:S513-516, 1995
 
16) Langer R, et al:Tissue engineering. Science 260:920-926, 1993
PubMed

第8章 人工血管と再生医療

P.125 掲載の参考文献
1) 冨澤康子:人工血管この1年の動き. 人工臓器33:191-197, 2004
 
2) Ando M, et al:Autologous tissue-fragmented extracardiac conduit with rapid, stable endothelialization due to angiogenesis. Jpn J Thorac Cardiovasc Surg 48:153-160, 2000
PubMed
3) Noishiki Y, et al:Autocrine angiogenic vascular prosthesis with bone marrow transplantation. Nat Med 2:90-93, 1996
PubMed
4) Tomizawa Y, et al:Coronary bypass grafting with biological grafts in a canine model. Circulation 90[part2];[II]160-166, 1994
 
5) Huynh T, et al:Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol 17:1083-1086, 1999
PubMed
6) Shin'oka T, et al:Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 344:532-533, 2001
 
7) Hibino N, et al:The tissue-engineered vascular graft using bone marrow without culture. J Thorac Cardiovasc Surg 129:1064-1070, 2005
PubMed
8) Kaushal S, et al:Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7:1035-1040, 2001
PubMed
9) Weinberg CB, et al:A blood vessel model constructed from collagen and cultured vascular cells. Science 231:397-400, 1986
PubMed
10) L'Heureux N, et al:A completely biological tissue-engineered human blood vessel. Faseb Journal 12:47-56, 1998.
 
11) Niklason LE, et al:Functional arteries grown in vivo. Science 284:489-493, 1999
 
12) Campbell JH, et al:Novel vascular graft grown within recipients own peritoneal cavity. Circulation Research 85:1173-1178, 1999
 
13) Fauza DO, et al:Fetal tissue engineering:diaphragmatic replacement. J Pediatr Surg 36:146-151, 2001
PubMed
14) Saito N, et al:Feasibility of the Inoue single-branched stent-graft implantation for thoracic aortic aneurysm or dissection involving the left subclavian artery:short-to medium-term results in 17 patients. J Vasc Surg 41:206-212;discussion 212, 2005
 
P.129 掲載の参考文献
1) Langer R, et al:Tissue engineering. Science 260:920-926, 1993
PubMed
2) Shinoka T, et al:Tissue-engineered heart valves. Autologous valve Ieaflet replacement study in a lamb model. Circulation 94:II 164-168, 1996
 
3) Shinoka T, et al:Tissue engineering heart valves:valve leaflet replacement study in a lamb model. Ann Thorac Surg 60:S513-516, 1995
 
4) Shinoka T, et al:Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 115:536-545; discussion 545-546, 1998
 
5) Watanabe M, et al:Tissue-engineered vascular autograft:inferior vena cava replacement in a dog model. Tissue Eng 7:429-439, 2001
 
6) Shinoka T, et al:Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 344:532-533, 2001
 
7) McKay R:Stem cells-hype and hope. Nature 406:361-364, 2000
PubMed
8) Noishiki Y, et al:Autocrine angiogenic vascular prosthesis with bone marrow transplantation. Nat Med 2:90-93, 1996
PubMed
9) Matsumura G, et al:First evidence that bone nlarrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 108:1729-1734, 2003
 
10) Matsumura G, et al:Successful application of tissue engineered vascular autografts:clinical experience. Biomaterials 24:2303-2308, 2003
PubMed
11) Shinoka T, et al:Midterm clinical results of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surgery 129:1330-1338, 2005
 
P.132 掲載の参考文献
1) Chakfe N, et al:Biocompatibility and biofunctionality of a gelatin impregnated polyester arterial prosthesis. Polymers& Polymer Composites 1:229-251, 2005
 
2) Utoh J, et al:Postoperative inflamnmatory reactions to sealed Dracon prostheses:a comparison of Gelseal and Hemashield. J Cardiovasc Surg (Torino) 38:287-290, 1997
PubMed
3) Hasegawa T, et al:Autologous fibrin-coated small caliber vascular prostheses improve the antithrombogenicity by less immunological response. (6th annual conference on Arterioscler Thromb Vasc Biol, abstract#184)
 
4) 安達秀雄ほか:治療成績と今後の課題-シールドグラフトによる大動脈置換術. 日血外会誌6:393-398, 1997
 
5) 宇藤純一ほか:人工血管の術後口径拡張に関する臨床的評価法 ノギスを用いた術中口径計測法の応用. 日血外会誌6:393-398, 1997
 
6) Wilson SE, et al:Late disruption of Dacron aortic grafts. Ann Vasc Surg 11:383-386, 1997
PubMed
7) Seeger JM, et al:Management of patients with prosthetic vascular graft infection. Am Surg 66:166-177, 2000
PubMed
8) Jacobs MJ, et al:In-situ replacement and extra-anatomic bypass for the treatment of infected abdominal aortic grafts. Eur J Vasc Surg 5:83-86, 1991
PubMed
9) Young RM, et al:The results of in situ prosthetic replacement, for infected aortic grafts. Am J Surg 178:136-140, 1999
PubMed
10) Coggia M, et al:Experimental treatment of vascular graft infection due to Staphylococcus epidermidis by in situ replacement with a rifampin-bonded polyester graft. Ann Vasc Surg 15:421-429, 2001
PubMed
11) Goeau-Brissonniere O, et al:Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft. J Vasc Surg 19:739-741, 1994
 
12) Lachapelle K, et al:Antibacterial activity, antibiotic retention, and infection resistance of a rifampin-impregnated gelatin-sealed Dacron graft. J Vasc Surg 19:675-682, 1994
 
13) Muhl E, et al:Local application of vancomycin for prophylaxis of graft infection:release of vancomycin from antibiotic-bonded Dacron grafts, toxicity in endothelial cell culture, and efficacy against graft infection in an animal model. Ann Vasc Surg 10:244-253, 1996
 
P.138 掲載の参考文献
1) Dake MD, et al:Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med 331 (26):1729-1734, 1994
PubMed
2) Inoue K, et al:Aortic arch reconstruction by transluminally placed endovascular branched stent graft. Circulation 100 (19 Suppl):II 316-321, 1999
 
3) Chuter TA, et al:Modular branched stent graft for endovascular repair of aortic arch aneurysm and dissection. J Vasc Surg 38 (4):859-863, 2003
PubMed
4) Stanley BM, et al:Fenestration in endovascular grafts for aortic aneurysm repair:new horizons for preserving blood flow in branch vessels. J Endovasc Ther 8 (1):16-24, 2001
 
5) Kato M, et al:Outcomes of stent-graft treatment of false lumen in aortic dissection. Circulation 98:II 305-312, 1998
 
6) Kusagawa H, et al:Changes in false lumen after transluminal stent-graft placement in aortic dissections:six years experience. Circulation 111 (22):2951-2957, 2005
PubMed
7) Kato M, et al:New graft-implanting method for thoracic aortic aneurysm or dissection with a stented graft. Circulation 94:III 188-193, 1996
PubMed
8) Kato M, et al:The results of total arch graft implantation with open stent-graft placement for type A aortic dissection. J Thorac Cardiovasc Surg 124:531-540, 2002
PubMed
9) Hosokawa H, et al:Successful endovascular repair of juxtarenal and suprarenal aortic aneulysms with a branched stent graft. J Vasc Surg 33 (5):1087-1092, 2001
 
10) Greenberg RK, et al:Endovascular management of juxtarenal aneurysms with fenestrated endovascular grafting. J Vasc Surg 39 (2):279-287, 2004
PubMed
11) Veith FJ, et al:Treatment of ruptured abdominal aneurysms with stent grafts:anew gold standard? Semin Vasc Surg 16 (2):171-175, 2003
 
12) Zarins CK, et al:Endovascular repair or surveillance of patients with small AAA. Eur J Vasc Endovasc Surg 29 (5):496-503; discussion 504, 2005
 
P.143 掲載の参考文献
1) Voorhees AB Jr, et al:The use of tubes constructed from vinyon "N" cloth in bridging arterial defects. A preliminary report. Ann Surg 135:332-336, 1952
 
2) Wesolowski SA:Evaluation of tissue and prosthetic vascular grafts; Charles C Thomas Publisher, Springfield, IL, p25-68, 1962
 
3) Mzuno T, et al:Analysis of the two processes, wound repair and early changes in carcinogenesis by the use of millipore filter imnplanting; The possible role of a heparin-like compound in cell interaction. J Fac Sci Univ Toktyo IV 11:475-495, 1959
 
4) Okoshi T:New concept of microporous structure in small diameter vascular prostheses. Artif Organs 19:27-31, 1995
 
5) Creech O Jr, et al:Vascular prostheses:Report of the committee for the study of vascular prostheses of the society for vascular surgery 41:62-75, 1957
 
6) Noishiki Y:Biochemical response to dacron vascular prosthesis. J Biomed Mater Res 10:759-767, 1976
PubMed
7) Bascon JU:Gelatin sealing to prevent blood loss from knitted arterial graft. Surg 50:504-512, 1961
 
8) Noishiki Y, et al:The vicious cycle of nonhealing neointima in fabric vascular prostheses. Artif Organs 19:7-16, 1996
 
9) Berger K, et al:Healing of arterial prosthesis in man:its incompleteness. Ann Surg 175:118-127, 1972
PubMed
10) Hasegawa N, et al:Evaluation of long-term cultured endothelial cells as a model system for studying vascular aging. Mech Ageing Dev 46:111-123, 1988
PubMed
11) Herring MB, et al:Endothelial seeding of polytetrafluoroethylene popliteal bypass. J Vasc Surg 6:114-118, 1987
PubMed
12) Noishiki Y, et al:Rapid endothelialization of vascular prostheses by seeding autologous venous tissue fragments. J Thorac Cardiovasc Surg 104:770-778, 1992
PubMed
13) Noishiki Y, et al:Autocrine angiogenic vascular prosthesis with bone marrow transplantation. Nature Medicine 2:90-93, 1996
PubMed
14) Noishiki Y:Evaluation of a new vascular prsothesis fabricated from ultrafine polyester fiber. Trans ASAIO 32:309-314, 1984
 

第9章 血管再生のための幹細胞生物学

P.148 掲載の参考文献
1) Risau W:Mechanisms of angiogenesis. Nature 386:671-674, 1997
PubMed
2) Sato TN:Vascular development:molecular logic for defining arteries and veins. Curr Opin Hematol 10:131-135, 2003
PubMed
3) Hong YK, et al:Development of the lymphatic vascular system:a mystery unravels. Dev Dyn 231:462-473, 2004
PubMed
4) Cammeliet P:Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395, 2000
 
5) Ara T, et al:The role of CXCL12 in the organ-specific process of artery formation. Blood 105:3155-3161, 2005
PubMed
6) Lawson ND, et al:Arteries and veins:making a difference with zebrafish. Nat Rev Genet 3:674-682, 2002
PubMed
7) Uyttendaele H, et al:Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci USA 98:5643-5648, 2001
PubMed
8) You LR, et al:Suppression of Notch signaling by the COUP-TFII transcription factor regulates vein identity. Nature 435:98-104, 2005
PubMed
9) Morisada T, et al:Angiopoietin-1 promotes LYVE-1-positive lymphetic uessel formation Blood 105:4649-4656, 2005
PubMed
10) Cao R, et al:PDGF-BB induces intratumoral lymphoangiogenesis and promotes lymphatic metastasis Cancer Cell 6:333-345, 2004
 
11) Yamashita J, et al:Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92-96, 2000
PubMed
12) Yamashita JK:Differentiation and diversification of vascular cells from embryonic stem cells. Int J Hematol 80:1-6, 2004
PubMed
13) Mukouyama YS, et al:Sensory nerves determine the pattem of arterial differentiation and blood vessel branching in the skin. Cell 109:693-705, 2002
 
14) Gilbert SF:Lateral plate mesoderm and endoderm. "Developmental Biology (6th)", SINAUER Associates, Sunderland, Massachusetts, p482, 2000
 
P.153 掲載の参考文献
1) Asahara T, et al:Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967, 1997
PubMed
2) Folkman J, et al:Angiogenic factors. Science 235:442-447, 1987
PubMed
3) Isner M, et al:Clinical evidence of allgiogenesis after arterial gene transfer of phVEGF165 in patient with ischemic limb. Lancet 348:370-374, 1996
 
4) Risau W, et al:Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies. Development 102:471-478, 1988
PubMed
5) Isner JM, et al:Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J CIin Invest 103:1231-1236, 1999
 
6) Asahara T, et al:Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228, 1999
PubMed
7) Asahara T, et al:VEGF contributes to post-natal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18:3964-3972, 1999
 
8) Kalka C, et al:Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86:1198-1202, 2000
PubMed
9) Takahashi T, et al:Ischemia-and cytokine-indced mobilization of bone marrow derived endothehal progenitor cells for neovascularization. Nat Med 4:434-438, 1999
 
10) Kalka C, et al:Transplantation of ex-vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97:3422-3427, 2000
PubMed
11) Kawamoto A, et al:Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103:634-637, 2001
PubMed
12) Kawamoto A, et al:Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107:461-468, 2003
PubMed
13) Iwaguro H, et al:Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105:732-738, 2002
PubMed
14) Murasawa S, et al:Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 106:1133-1139, 2002
PubMed
15) Iwasaki H, et al:Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery from myocardial infarction. J Am Coll Cardiol 45 (Suppl A):198A, 2005
 
P.156 掲載の参考文献
1) Isner JM, et al:Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348:370-374, 1996
PubMed
2) Asahara T, et al:Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967, 1997
PubMed
3) Tateishi-Yuyama E, et al:Therapeutic angiogenesis for patients With limb ischaemia by autologous transplantation of bone-marrow cells:a pilot study and a randomised controlled trial. Lancet 360:427-435, 2002
 
4) Inaba S, et al:Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis? Lancet 360:2083; author reply 2084, 2002
 
5) Hristov M, et al:Endothelial progenitor cells:isolation and characterization. Trends Cardiovasc Med 13:201-206, 2003
PubMed
6) Quirici N, et al:Differentiation and expansion of endothelial cells from human bone marrow CD133 (+) cells. Br J Haematol 115:186-194, 2001
PubMed
7) Asahara T, et al:Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228, 1999
PubMed
8) Cho HJ, et al:Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation 108:2918-2925, 2003
PubMed
9) Kalka C, et al:Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97:3422-3427, 2000
PubMed
10) Aicher A, et al:Mobilizing endothelial progenitor cells. Hypertension 45:321-325, 2005
PubMed
11) Rupp S, et al:Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. Basic Res Cardiol 99:61-68, 2004
PubMed
12) Landmesser U, et al:Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 110:1933-1939, 2004
PubMed
13) Powell TM, et al:3rd. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 25:296-301, 2005
 
14) Heissig B, et al:Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligaand. Cell 109:625-637, 2002
PubMed
15) Chen JZ, et al:Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 107:273-280, 2004
PubMed
16) Krankel N, et al:Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb Vasc Biol 25:698-703, 2005
PubMed
17) Yamaguchi J, et al:Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107:1322-1328, 2003
PubMed
18) Ceradini DJ, et al:Progenitor cell trafficking is regulated by hypoxic gradients through HIF-l induction of SDF-1. Nat Med 10:858-864, 2004
 
19) Biancone L, et al:Role of L-selectiin in the vascular homing of peripheral blood-derived endothelial progenitor cells. J Immunol 173:5268-5274, 2004
PubMed
20) Chavakis E, et al:Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 201:63-72, 2005
PubMed
21) Urbich C, et al:Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat Med 11:206-213, 2005
PubMed
P.159 掲載の参考文献
1) Asahara T, et al:Isolation of putative progenitor endothelial cells for angiogenesis. Science 14:964-967, 1997
 
2) Tateishi-Yuyama E, et al:Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells:a pilot study and a randomised controlled trial. Lancet 10:427-435, 2002
 
3) Nakagami H, et al:Novel autologous cell therapy in ischemic limb diseasethrough growth factor secretion by cultured adipose tissue-derived stromal cells (in submission).
 
4) Morishita R, et al:Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 44:203-209, 2004
PubMed
5) Yoon YS, et al:VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest 111:717-725, 2003
PubMed

第10章 ペースメーカー・植込み型除細動器

P.164 掲載の参考文献
1) Elmqvist R, et al:An implantable cardiac pacemaker for the heart. In "Proceedings of the second international conference on electronics, Paris 1959 (Smyth CN, ed)", Iliffe & Sons, London, 1960
 
2) Nakazato Y, et al:Acute and chronic stability of atrial screw-in lead. Jpn Circ J 55:665-668, 1991
PubMed
3) Nitzsche R, et al:Endless-Loop tachycardias:Description and first clinical results of a new fully automatic protection algorithm. PACE 13:1711-1718, 1990
PubMed
4) Mayumi H, et al:Use of automatic mode change between DDD and AAI to facilitate native atrioventricular conduction in patients with sick sinus syndrome or transient atrioventricular block. PACE 19:1740-1747, 1996
PubMed
5) Gestrich B, et al:Influence of closed-loop pacemaker implantation on patients quality of life:RAPID study findings. Prog Biomed Res 8:55-62, 2002
 
6) Wiberg S, et al:Effect of right atrial overdrive pacing in the prevention of symptomatic paroxysmal atrial fibrillation:A multicenter randomized study, the PAF-PACE study. PACE 26:1841-1848, 2003
 
7) Lee MA, et al (for ATTEST Investigators):The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency. Results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 41:1926-1932, 2003
PubMed
8) Carlson MD, et al (for ADOPT Investigators):A new pacemaker algorithm for the treatment of atrial fibrillation. J Am Coll Cardiol 42:627-633, 2003
 
9) Lozano IF, et al:Paroxysmal atrial fibrillation prevention bu pacing in patients with pacemaker indication. Europace 5:267-273, 2003
 
10) Bailin SJ, et al:Prevention of chronic atrial fibrillation by pacing in the region of Bachmanns bundle. J Cardiovasc Electrophysiol 12:912-917, 2001
PubMed
11) Padeletti L, et al:Randomized crossover comparison of right atrial appendage pacing versus intraatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J 142:1047-1055, 2001
 
12) Mirza I, et al:Biatrial pacing for prevention for paroxysmal atrial fibrillation. A randomized prospective study into the suppression of paroxysmal atrial fibrillation using biatrial pacing. J Am Coll Cardil 40:457-463, 2002
 
13) Saksena S, et al:Improved suppression of recurrent atrial fibrillation with dual-site atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 40:1140-1150, 2002
PubMed
14) Gillis AM, et al (for GEM III AT Worldwide Investigators):Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol 40:1653-1659, 2002
 
15) Berger T, et al:The influence of high versus normal impedance ventricular leads on pacemaker longevity. PACE 26:2116-2120, 2003
PubMed
P.171 掲載の参考文献
1) The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with inlplantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576-1583, 1997
 
2) Connolly SJ, et al:Canadian implantable defibrillator study (CIDS):a randomized trial of the implantable cardioverter defibrillator against amiodarone [comment]. Circulation 101 (11):1297-1302, 2000
PubMed
3) Kuck KH, et al:Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest:the Cardiac Arrest Study Hamburg (CASH). Circulation 102 (7):748-754, 2000
PubMed
4) Connolly SJ, et al:Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J 21:2071-2078, 2000
PubMed
5) Domanski MJ, et al:Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of Ieft ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. J Am Coll Cardiol 34:1090-1095, 1999
 
6) Sheldon R, et al:Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy:the Canadian Implantable Defibrillator Study. Circulation 101:1660-1664, 2000
PubMed
7) Moss AJ, et al:Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933-1940, 1996
PubMed
8) Moss AJ, et al:The Multicenter Automatic Defibrillator Implantation Trial ll Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl Med 346:877-883, 2002
 
9) Buxton AE, et al:Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Medicine 342:1937-1945, 2000
 
10) Bardy GH, et al:(The Sudden Cardiac Death in Heart Failure Trial[SCD-HeFT] investigators):Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225-237, 2005
 
11) Tannno K, et al:Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? Circ J 69:19-22, 2005
 
12) Kadish A, et al:Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. New Engl J Med 350:2151-2158, 2004
PubMed
13) Kakishita M, et al:Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. JACC 36 (5):1646-1653, 2000
PubMed
14) Brugada J, et al:Determinants of sudden cardiac death in individuals with the electrocardiographic pattem of Brugada syndrome and no previous cardiac arrest. Circulation 108:3092-3096, 2003
 
15) 鎌倉史郎:Brugada症候群の予後-わが国の登録試験より-. Medical Topics不整脈,2005 (in press)
 
16) Bristow MR, et al:Cardiac resynchronization therapy (CRT) reduces hospitalizations, and CRT+ an implantable defibrillator (CRT-D) reduces mortality in chronic heart failure:Preliminary results of the COMPANION trial. N Engl J Med 350:2140-2508, 2004
 
P.176 掲載の参考文献
1) Baldasseroni S, et al:Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure:a report from the Italian network on congestive heart failure. Am Heart J 143:398-405, 2002
PubMed
2) Abraham WT, et al:Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845-1853, 2002
PubMed
3) Sutton MG, et al:Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107:1985-1990, 2003
 
4) Cleland JG, et al:The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539-1549, 2005
PubMed
5) Abraham WT, et al:Effects of Cardiac Resynchronization on Disease Progression in Patients With Left Ventricular Systolic Dysfunction, an Indication for an Implantable Cardioverter-Defibrillator, and Mildly Symptomatic Chronic Heart Failure. Circulation 110:2864-2868, 2004
PubMed
6) Sogaard P, et al:Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 40:723-730, 2002
PubMed
7) Yu CM, et al:Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation 110:66-73, 2004
PubMed
8) Achilli A, et al:Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS. J Am Coll Cardiol 42:2117-2124, 2003
PubMed
9) Bristow MR, et al:Cardiac resynchronization therapy with or without implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140-2150, 2004
 

第11章 呼吸器系

P.183 掲載の参考文献
1) Zwischenburger JB:Development of an implantable artificial lung. ASAIO J 47 (4):316-320, 2001
 
2) Zwischenburger JB, et al:Percutaneous extracorporeal arteriovenous CO2 removal for severe respiratory failure. Ann Thorac Surge 68:181-187, 1999
 
P.189 掲載の参考文献
1) 清水信義ほか:21世紀への人工臓器. 先端医療技術研究所, 東京,p143-148, 1999
 
2) 松川兼一ほか:先端医療を支える新しい治療法 (7) 液体呼吸. 医薬の門:287-294, 2000
 
3) Hirschl R:Currrent experience with liquid ventilation. Paediatric Respiratory Reviews 5 (Suppl A):S339-345, 2004
 
4) Wolfson M, et al:Liquid ventilation:an adjunct for respiratory management. Pediatr Anaesth 14 (1):15-23, 2004
 
5) Komori E, et al:Partial liquid ventilation does not affect BALF TNF-, MIP-2, CINC-1 concentrations, or CD11b cell surface expression, but does increase macrophage proportion among BALF cells in the acute phase of rat LPS-induced lung injury. Acta Med Okayama 57 (3) 1133-141, 2003
 
6) Greenspan J, et al:Liquid Ventilation of preterm baby. Lancet 2:8671, 1989
PubMed
7) Gauger P, et al:Initial experience with partial liquid ventilation in pediatric patients with the acute respiratory distress syndrome. Crit Care Med 24 (1):16-22, 1996
PubMed
8) Hirschl R, et al:Initial experience with partial liquid ventilation in adult patients with the Acute Respiratory Distress Syndrome. JAMA 275 (5):383-389, 1996
PubMed
9) Hirschl R:Partial Liquid Ventilation in Adult Patients with ARDS:A Multicenter Phase I-II Trial. Ann Surg 228 (5) 692-700, 1998
PubMed
10) Hirschl R, et al:Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. Am J Respir Crit Care Med 165 (6):781-787, 2002
PubMed
11) Wiedermann, Alliance Pharmaceutical Corp. Announces Preliminary Results of LiquiVent Phase 2-3 Clinical study, 2001
 
12) Hirschl RB, et al:Evaluation of gas exchange, pulmonary compliance, and lung injury during total and partial liquid ventilation in the acute respiratory distress syndrome. Crit Care Med 24 (6):1001-1008, 1996
PubMed
13) Marraro G, et al:Perfluorocarbon broncho-alveolar lavage and liquid ventilation versus saline broncho-alveolar lavage in adult guinea pig experimental model of meconium inhalation. lntensive Care Med 24:501-508, 1998
 
14) West J:呼吸の生理第3版. 医学書院, 東京, p152-153, 1997
 
15) Hirschl R, et al:Development and application of a simplified liquid ventilator. Crit Care Med 23 (1):157-163, 1995
PubMed
16) Meinhardt J, et al:Development and application of a double-piston configured, total-liquid ventilatory support device. Crit Care Med 28 (5):1483-1488, 2000
PubMed
17) Sekins K, et al:Recent innovations in total liquid ventilation system and component design. Biomed Instrum Technol 33 (3):277-284, 1999
PubMed
18) Tredici S, et al:Aprototype of a liquid ventilator using a novel hollow-fiber oxygenator in a rabbit model. Crit Care Med 32 (10):2104-2109, 2004
 
19) Baba Y, et al:Assessment of the development of choked flow during total liquid ventilation. Crit Care Med 32 (1):201-208, 2004
PubMed
20) Foley D, et al:Total liquid ventilation:dynamic airway pressure and the development of expiratory flow limitation. ASAIO J 50 (5):485-490, 2004
PubMed
21) Cox C, et al:Long-Term Tidal Iiquid Ventilation in Premature Lambs:Physiologic, Biochemical and Histological Correlates. Biol Neonate 84:232-242, 2003
 
22) Bull J, et al:Distribution dynamics of perfluorocarbon delivery to the lungs:an intact rabbit model. J Appl Physiol 96:1633-1642, 2004
 
P.193 掲載の参考文献
1) Grillo HC:Circumferential resection and reconstruction of the mediastinal and cervical trachea. Annals of surgery 162:374-388, 1965
PubMed
2) Neville WE, et al:Clinical experience with the silicone tracheal prosthesis. J Thorac Cardiovasc Surg 99:604-613, 1990
PubMed
3) Pearson F, et al:The reconstruction of circumferential tracheal defects with a porous prosthesis. J Thorac Cardiovasc Surg 55:605-616, 1968
PubMed
4) Shimizu Y, et al:Study of artificial trachea using mesh. Jpn J Artif Organs 12:486-489, 1983
 
5) 上田 実ほか:ティッシュエンジニアリング, 名古屋大学出版会, 名古屋, p20-42, 1999
 
6) 立花 隆ほか:人体再生. 中央公論新社, 東京, p45-76, 2000
 
7) 中村達雄ほか:人工気管. 第10回再生医工学委員会資. 料集:181-188, 1998
 
8) Okumura N, et al:Experimental study on a new tracheal prosthesis made from collagen-conjugated mesh. J Thorac Cardiovasc Surg 108:337-345, 1994
 
9) Teramachi M, et al:Intrathoracic tracheal reconstruction with a collagen-conjugated prosthesis-evaluation of the efficacy of omental wrapping.-J Thorac Cardiovasc Surg 113:701-711, 1997
PubMed
10) Sekine T, et al:Experimental Carinal Replacement with a Y-shaped Collagen-conjugated Prosthesis. Thoracic Cardiovascular Surgeon:48 (3):125-129, 2000
PubMed
11) Sekine T, et al:Carinal Reconstruction with a Y-shaped Collagen-conjugated Prosthesis. Thorac Cardiovasc Surg 119 (6):1162-1168, 2000
PubMed

第12章 泌尿器系

P.197 掲載の参考文献
1) Makino S, et al:Cardiomyocytes can be generated from marrow stromal cells in vitro. J CIin Invest 103:697-705, 1999
 
2) Studer L, et al:Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1:290-295, 1998
 
3) Asahara T, et al:Isolation of putative endothelial cells for angiogenesis. Science 275:964-967, 1997
PubMed
4) Bonner-Weir S, et al:A second pathway for regeneration of adult exocrine and endocrine pancreas:a possible recapitulation of embryonic development. Diabetes 42:1715-1720, 1993
PubMed
5) 日本透析医学会統計調査委員会:我が国の慢性透析療法の現況, 2003年12月31日現在. 日本透析医学会, 東京, 2004
 
6) Saito A, et al:Maintaining low concentration of plasma β2-microglobulin with continuous slow hemofiltration. Nephrology Dial Transplant 10 (Suppl 3):52-56, 1995
 
7) Saito A:Research in the development of a wearable bioartificial kidney with a continuous hemofilter and a bioartificial tubule device using tubular epithelial cells. Artif Organs 28:58-63, 2004
 
8) Saito A, et al:Regeneration of peritoneal effluent by Madin-Darby canine kidney cells-lined hollow fibers. Mater Sci & Eng C 6:221-226, 1998
 
9) Fujita Y, et al:Evaluation of active transport and morphological changes for bioartificial renal tubule device using MDCK cells. Tissue Eng 8:13-24, 2002
PubMed
10) Terashima M, et al:Evaluation of water and electrolyte transport of tunular epithelial cells under osmotic and hydraulic pressure for development of bioartificial tubules. Artif Organs 25:209-212, 2001
PubMed
11) Kanai N, et al:Effect of extracellular matrix on renal epithelial cell attachment on the polmer substrate. Artif Organs 23:114-118, 1999
 
12) Ozgen N, et al:Evaluation of long-term transport ability of a bioartificial renal tubule device using LLC-PK1. Nephrol Dial Transplant 19:2198-2207, 2004
 
13) Asano M, et al:Renal proximal tubular metabolism of protein-linked pentosidine, an advanced glycation end product. Nephron 91:688-694, 2002
PubMed
14) Sato Y, et al:Evaluation of Proliferation and Functional Differentiation of LLC-PK1 Cells on Porous Polymer Membranes for the Development of a Bioartificial Renal Tubule Device. Tissue Eng 11:1506-1515, 2005
PubMed
15) Humes HD, et al:Tissue engineering of a bioartificial renal tubule assist device:In vitro transport and metabolic characteristics. Kidney Int 55:2502-2514, 1999
PubMed
16) Tsuruoka S, et al:Removal of digoxin and doxorubicin by multidrug resistant protein-overexpressed cell culture in hollow fiber. Kidney Int 56:154-163, 1999
 
17) Tsuruoka S, et al:Specific therapy of digoxin intoxication in dogs by hybrid kidney overexpressing multidrug resistance protein. Kidney Int 62:1332-1337, 2002
PubMed
18) Humes HD, et al:Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat Biotechnol 17:451-455, 1999
PubMed
19) Humes HD, et al:Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 66:1578-1588, 2004
PubMed
20) Tatsumi E, et al:Developmemt of a novel integrated heart-lung assist device-A heparin-coated, preprimed, all-in-one system. ASAIO Ab 20A:1998
 
21) Tatsumi E, et al:Development of an ultracompact integrated heart-lung assist device. Artificial Organs 23:518-523, 1999
PubMed
22) Ishihara K, et al:Hemocompatibility on graft copolymers composed of poly (2-methacryloyloxyethyl phosphorylcoline) side chain and poly (n-butyl methacrylate) backbone. J Biomed Mater Res 28:225-232, 1994
 
23) Ishihara K, et al:Improvement of blood compatibility on cellulose dialysis membrane with a novel biomedical polymer having a phospholipid polar group. Artif Organs 18:559-564, 1994
 
24) Milici AJ, et al:The formation of fenestrations and channelsby capillary endothelium in vitro. Proc Natl Acad Sci USA 82:6181-6185, 1985
 
25) Kowolik CM, et al:Cre-mediated reversible immortalization of human renal proximal tubular epithelial cells. Oncogene advanced online publication:1-8, 2004. 6. 24
 
26) Fujita Y, et al:Transcellular water transport and stability of expression in aquaporin1-transfected LLC-PK1 cells in the development of a portable bioartificial renal tubule device. Tissue Eng 10:711-722, 2004
 
P.203 掲載の参考文献
1) 日本透析医学会統計調査委員会:図説我が国の慢性透析療法の現況2004年12月31日現在. p2, 2005
 
2) Eknoyan G, et al:NKF-K/DOQI clinical practice guidelines:update 2000. Am J Kidney Dis 37 (Suppl 1):S5, 2001
 
3) Locatelli F, et al:Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments:the Registro Lombardo Dialisi E Trapianto. Kidney Int 55:286, 1999
 
4) Port FK, et al:Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics:results from the USRDS dialysis morbidity and mortality study. Am J Kidney Dis 37:276, 2001
PubMed
5) Eknoyan G, et al:Hemodialysis (HEMO) Study Group:Effect of dialysis dose and membrane flux in maintenance hemodialysis New England Journal of Medicine 347 (25):2010, 2002
 
6) Chertow GM, et al:Exploring the reverse J-shaped curve between urea reduction ratio and mortality, Kidney Int 56:1872, 1999
 
7) Daugirdas JT:Second generation Iogarithmic estimates of single-pool variable volume Kt/V:an analysis of error. J Am Soc Nephrol 4:1205-1213, 1993
 
8) 峰島三千男:特集血液採取なしで透析量 (KT/V) を推定する方法はあるのでしょうか? クリニカルエンジニアリング 16 (4):368-369, 2005
 
9) 石和希伊子ほか:透析液廃液溶質除去モニターを用いた適正透析への模索. 日本血液浄化技術研究会会誌12 (1):31-33, 2005
 
10) Rindi P, et al:Clinical experience with a new hemodiafiltrat-ion (HDF) system. ASAIO Transactions 34:765, 1988
PubMed
11) Dellanna F, et al:Intemal filtration-advantage in haemodialysis? Nephrol Dial Transplant 11 (Suppl 2):83, 1996
 
12) 川西秀樹ほか:新たな透析液水質基準と血液浄化器の機能分類-第49回日本透析医学会コンセンサスカンファレンス「血液浄化器の新分類-内部濾過と透析液水質による再評価」より-. 透析会誌38 (2):149-154,2005
 
P.207 掲載の参考文献
1) 川西秀樹ほか:新たな透析液水質基準と血液浄化器の機能分類. 透析会誌28 (2):149-154, 2005
 
2) Stiller S, et al:Backfiltration in hemodialysis with highly permeable membranes. Contr Nephrol 46:23-32, 1985
 
3) 細谷範行ほか:大量置換可能な透析器の性能評価-Plug透析器-. 人工臓器25:107-112, 1996
 
4) Yamashita, A:New dialysis membrane for removal of middle molecule uremic toxins. Amer J Kid Dis 38 (Supple 1):S217-219, 2001
 
5) 山下明泰:in vitro 評価による内部濾過促進型ダイアライザの溶質除去特性. 臨床透析18 (4):397-401, 2002
 
6) 吉村茂晴ほか:高速フーリエ変換を応用した内部濾過流量のモニタリング. 腎と透析55別冊HDF療法:03:165-166, 2003
 
7) Ronco C, et al:Anew scintigraphic method to characterize ultafiltration in hollow fiber dialyzers. Kidney Int 41:1383-1393, 1992
 
8) Sato Y, et al:Effect of hollow fiber length on solute removal and quantification of internal filtration rate by Doppler ultrasound. Int J Artif Organs 26:129-134, 2003
PubMed
9) Sakai Y, et al:Nondestructive evaluation of blood flow in a dialyzer using X-ray computed tomography. J Artif Organs 6:197-204, 2003
 

第13章 消化器系

P.214 掲載の参考文献
1) Nakazawa K, et al:Davelopment of a hybrid artficial liver using Polyurethane foam/hepatocyte spheroid culture in a preclinical pig experiment. Int J Artif Organs 25:51-60, 2002
 
2) http://www.med.kyushu-u.ac.jp/facul/koho/hybrid.html
 
3) http://www.optic.or.Jp/micro/info/16_itaku_kenkyu/OSS_4-2.pdf
 
4) http://vitaltherapies.com/
 
5) Kobayashi A, et al:Enhanced adhesion and survival efficiency of liver cells in culture dishes coated with a lactose-carrying styrene homopolymer. Makromol Chem Rapid Commun 7:645-650, 1986
 
6) Kobayashi K et al:Culturing hepatocytes on lactose-carrying Polystyrene layer via asialoglycopretein receptor-mediated interactions. Methods Enzymol 247:409-418, 1994
PubMed
7) Tobe S, et al:Receptor-Mediated Formation of Multilayer Aggregates of Primary Cultured Adult Rat Hepatocytes on Lactose-Substituted Polystyrene, Biochem Biophys Res Commun 184:225-230, 1992
PubMed
8) Nonaka H, et al:Development of Highly Functional Long-Term Culture Method of Liver Slice Embedded in Agarose Gel for Bioartificial Liver. Cell Trans 1:491-498, 2003
 
9) Nagaoka M, et al:Immobilized E-cadherin model can enhance cell attachment and differentiation of primary hepatocytes but not proliferation. Biotechnol Lett 24:1857-1862, 2002
 
10) Forbes S, et al:Hepatic stem cells. J Pathol 197:510-518, 2002
PubMed
11) Mori A, et al:Analysis of stem cell factor for mast cell proliferation in the human myometrium. Mol Hum Reprod 3:411-418, 1997
PubMed
12) Kobayashi N, et al:Establishment of a reversibly immortalized human hepatocyte cell line by using Cre/loxP site-specific recombination. Transplant Proc 32:1121-1122, 2000
PubMed
13) Kato K, et al:Effect of hepatocyte growth factor on the proliferation of transplanted hepatocytes in the spleen. Transplant Proc 29:2029-2031, 1997
PubMed
P.219 掲載の参考文献
1) Shichiri M, et al:Wearable-type artificial endocrine pancreas with needle-type glucose sensor. Lancet ii:1129-1131, 1982
 
2) Nishida K, et al:Development of a ferrocene-mediated needle-type glucose sensor covered with newly designed biocompatible membrane, 2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate. Med Prog Technol 21:91-103, 1995
 
3) Hashiguchi Y, et al:Development of a miniaturized glucose monitoring system by combining a needle-type glucose sensor with microdialysis sampling method;Long-term subcutaneous tissue glucose monitoring in ambulatory diabetic patients. Diabetes Care 17:387-396, 1994
PubMed
4) Mastrototaro J:The MiniMed Continuous Glucose Monitoring System (CGMS). J Pediatr Endocrinol Metab 12 (Suppl 3):751-758, 1999
 
5) Hovorka R, et al:Closing the loop:the adicol experience. Diabetes Technol Ther 6:307-318, 2004
PubMed
6) Diabetes Research in Children Network (DIRECNET) Study Group:The accuracy of the GlucoWatch G2 biographer in children with type l diabetes:results of the diabetes research in children network (DirecNet) accuracy study. Diabetes Technol Ther 5:791-800, 2003
 
7) Caduff A, et al:First human experiments with a novel non-invasive, non-optical continuous glucose monitoring system. Biosens Bioelectron 19:209-217, 2003
 
8) Shimoda S, et al:Closed-loop subcutaneous insulin infusion algorithm with a short acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas. Frontiers Med Biol Engng 8:197-211, 1997
 
9) Matsuo Y, et al:Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas. J Artif Organs 6:55-63, 2003
PubMed
10) Sekigami T, et al:Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas. J Artif Organs 7:91-100, 2004
PubMed
11) Steil GM, et al:Modeling beta-cell insulin secretion-implications for closed-loop glucose homeostasis. Diabetes Technol Ther 5:953-964, 2003
PubMed
12) Shichiri M, et al:Enhanced, simplified glucose sensors:long-term clinical application of wearable artificial endocrine pancreas. Artif Organs 22:32-42, 1998
PubMed
13) Renard E:Implantable closed-loop glucose-sensing and insulin delivery:the future for insulin pump therapy. Curr Opin Pharmacol 2:708-716, 2002
PubMed
P.224 掲載の参考文献
1) Shapiro et al:Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343 (4):230-238, 2000
PubMed
2) Lim F, et al:Microencapsulated islets as bioartificial endocrine pancreas. Science 210:908-909, 1980
PubMed
3) Soon-Shiong P, et al:Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343:950-951, 1994
 
4) Sun Y, et al:Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin lnves 98:1417-1422, 1996
 
5) Iwata H, et al:Agarose for a bioartificial pancreas. J Biomed Mater Res 26:967-977, 1992
PubMed
6) Park YG, et al:Microencapsulation of islets and model beads with a thin-alginate-Ba2+gel layer using centrifugation. Polym Adv Technol 9:734, 1998
 
7) Cruise GM, et al:Asensitivity study of the key parameters in the interfacial photopolymerization of poly (ethylene glycol) diacrylate upon porcine islets. Biotechnol Bioeng 57:655-665, 1998
 
8) Contreras JL, et al:A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine islets. Surgery 136:537-547, 2004
PubMed
9) Soria B:In-vitro differentiation of pancreatic β-cells. Differentiation 68:205-219, 2001
 
10) Dor Y, et al:Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-46, 2004
PubMed
11) Thomson JA, et al:Embryonic stem cell line derived from human blastocyst. Science 282:1145-1147, 1998
PubMed
12) Lumelsky N, et al:Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292:1389-1394, 2001
PubMed
13) Rajagopal J, et al:Insulin staining of ES cell progeny from insulin uptake. Science 299:363, 2003
PubMed
P.229 掲載の参考文献
1) UK Prospective Diabetes Study (UKPDS) Group:Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (9131):837, 1998
 
2) Nagakura T, et al:THE STUDY OF MICRO BLOOD SUGAR CONTROL DEVICE WITHOUT ENERGY SUPPLY FOR DIABETES THERAPY, Transducers'03, The 12th International Conference on Solid-State Sensors Actuators and Microsystems Technical Digest, Volume 2/2, p1209-1212, 2003
 
3) Ikuta K, et al:New micro stereo lithography for freely movable 3D structure-Super IH process with submicron resolution-, Proceedings of the IEEE International Workshop on Micro Electro Mechanical Systems (MEMS98), p290-295, 1998
 
4) Toshiaki Nagakura, et al:Auto-Regulated Osmotic Pump for insulin therapy by Sensing Glucose Concentration without Energy Supply, Sensors and Actuators B 34, p229-233, 1996
 

第14章 運動器系

P.234 掲載の参考文献
1) Yoshikawa H, et al:Clinical application of calcium hydroxyapatite ceramic in bone tumor surgery. Wise DL ed:Biomaterials and Bioengineering Handbook, Marcel Dekker, New York, p433455, 1999
 
2) Matsumine A, et al:Calcium hydroxyapatite ceramic implants in bone tumor surgery. A long-term follow-up study. J Bone Joint Surg 86B:719-725, 2004
 
3) Nishikawa M, et al:Calcium phosphate ceramics in Japan. Yaszemski MJ, et al ed:Biomaterials in Orthopedics, Marcel Dekker, New York, p425-436, 2004
 
4) Tamai N;et al:Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo. J Biomed Mater Res 59:110-117, 2002
PubMed
5) 吉川秀樹ほか:骨組織再生の促進. 整形外科の最新医療, 先端医療技術研究所,東京,p45-48, 2003
 
6) Myoui A, et al:Three-dimensionally engineered hydroxyapatite ceramics with interconnected pores as a bone substitute and tissue engineering scaffold. Yaszemski MJ, et al ed:Bio-materials in Orthopedics, Marcel Dekker, New York, p287-300, 2004
 
7) Ohgushi H, et al:Stem cell technology and bioceramics:from cell to gene engineering. J Biomed Mater Res 48:913-927, 1999
 
8) Nishikawa M, et al:Bone tissue engineering using novel interconnected porous hydroxyapatite ceramics combined with marrow mesenchymal cells:Quantitative and three-dimensional image analysis. Cell Transplantation 13:367-376, 2004
PubMed
9) Saito N, et al:Biodegradable poly,-lactic acid-polyethylene glycol block copolymers as a BMP delivery system for inducing bone. J Bone Joint Surg 83A:S92-98, 2001
 
10) Kaito T, et al:Potentiation of the activity of bone morphogenetic protein-2 in bone regeneration by a PLA-PEG/hydroxyapatite composite. Biomaterials 26:73-79, 2005
PubMed
11) Akita S, et al:Capillary vessel network integration by inserting a vascular pedicle enhances bone formation in tissue-engineered bone using interconnected porous hydroxyapatite ceramics. Tissue Engineering 10:789-795, 2004
PubMed
12) Tamai N, et al:A new biotechnology for articular cartilage repair:subchondral implantation of a composite of interconnected porous hydroxyapatite, synthetic polymer (PLA/PEG), and bone morphogenetic protein-2 (rhBMP-2). Osteoarthritis Cartilage 13:405-417, 2005
PubMed
13) 玉井宣行ほか:新規全気孔連通型HA多孔体NEOBONEを用いた骨欠損に対する治療. 関節外科23:100-107, 2004
 
14) 玉井宣行ほか:人工骨材料と骨 関節修復. 分子リウマチ 1:107-112, 2004
Medical*Online
15) 名井 陽ほか:連通多孔体型ハイドロキシアパタイトの開発と再生医療への展開.骨 関節 靭帯17:1205-1215, 2004
 
P.240 掲載の参考文献
1) 立石哲也:再生医工学をめぐる最近の動向. 人工臓器学会 31 (1):17-22, 2002
 
2) 立石哲也:再生医工学とバイオメカニクスの現状と展望.関節外科21 (10):111-116, 2002
 
3) 立石哲也ほか編著:再生医療工学. 工業調査会, 東京, 2004
 
4) Tateishi T, et al:Biodegradable porous scaffold for tissue engineering. J Artif Organs 5:77-83, 2002
 
5) Chen G, et al:Scaffold Design for Tissue Engineering. Macromol Biosci 2:67-77, 2002
 
P.244 掲載の参考文献
1) Oonishi H, et al:"Wear of high-dose gamma irradiated polyethylene in total joint replacement:long term radiological evaluation,"in Transactions of the 44th Annual Meeting. Orthopaedic Research Soc 23:97, 1998
 
2) Affatato S, et al:Wear behaviour of cross-linked polyethylene assessed in vitro under severe conditions. Biomaterials 26 (16):3259-3267, 2005
PubMed
3) Bradford L, et al:Fatigue crack propagation resistance of highly crosslinked polyethylene. Clin Orthop 429:68-72, 2004
PubMed
4) Harris WH:Highly cross-linked, electron-beam-irradiated, melted polyethylene:some pros. Clin Orthop 429:63-67, 2004
PubMed
5) De Aza AH, et al:Crack growth resistance of alumina, zirconia and zirconia toughened alumina ceramics for joint prostheses. Biomaterials 23 (3):937-945, 2002
PubMed
6) Tomita N, et al:Polymers for Artificial Joints, Polymeric Biomaterials Second Edition, p563-588, 2001
 
7) 大西啓靖ほか:界面バイオアクティブ骨セメント法を用い, 14～18年後に抜去された同一関節内におけるHA穎粒の介在部と非介在部の組織像の比較. 第34回日本人工関節学会抄録集:233, 2004
 
8) 馬渕清資ほか:解剖学的形状人工膝関節の高い接触圧力による塑性流動の予測.生体材料8 (4):462-471, 1991
 
9) 富田直秀:特集TKAにおける材料とデザイン上の諸問題. TKAにおける摩耗の評価とポリエチレンの改良. 関節外科 18 (3):320-324, 1999
 
10) 富田直秀:特集人工膝関節と可動域. 人工膝関節の工学デザインの限界と可動性. 骨関節靱帯17 (3):17-22, 2004
 
11) Woolson ST, et al:Comparison of primary total hip replacements performed with a standard incision or a mini-incision. J Bone Joint Surg Am 86-A (7):1353-1358, 2004.
PubMed
12) Kilgus DJ, et al:Catastrophic Wear of Tibial Polyethylene Inserts. Clinical Orthop and Related Res 273:223-231, 1991
 
13) Rimnac CM, et al:Post-Irradiation Aging of Ultra-High Molecular Weight Polyethylene. J Bone Joint Surg 76-A:1052-1056, 1994
PubMed
14) Tomita N, et al:Prevention of Fatigue Cracks in UHMWPE Joint Components by Addition of Vitamin E. J Biomed Res:48-45, 1999
 
15) Wolf C, et al:Tests of biocompatibility of α-tocopherol with respect to the use as a stabilizer in ultrahigh molecular weight polyethylene for articulating surfaces in joint endoprostheses. Joumal of Materials Science:Materials in Medicine 13 (No. 7):701-705, 2002
 
16) Yamamoto K, et al:Degradation diagnosis of ultra-high-molecular weight polyethylene with terahertz-time-domain spectroscopy. Applied Physics Letters (in press)
 
17) 柴田延幸ほか:ビタミンEの抗酸化作用がデラミネーションを含むUHMWPEの疲労特性の向上に及ぼす影響. 日本臨床バイオメカニクス学会誌25:357-362, 2004
 
18) 寺村 聡ほか:人工膝関節用Vitamin E添加超高分子量ポリエチレンの耐酸化性. 表面科学25 (9):568-572, 2004
 
19) Shibata N, et al:Numerical simulations on fatigue destruction of ultra-high molecular weight polyethylene using discrete element analyses. J Biomed Mater Res A 64A (3):570-582, 2003
 
20) Shibata N, et al:Defect initiation at subsurface grain boundary as a precursor of delamination in ultrahigh molecular weight polyethyiene. J Biomed Mater Res 67A:276-284, 2003
 
21) 森 亜希子ほか:ビタミンE添加UHMWPE材料の疲労特性-人工膝関節における lift-off を考慮して.生体材料21 (5):403-409, 2003
 
22) 富田直秀ほか:機能設計から環境設計へ.「安心」を育てる科学と医療,丸善,2005
 
23) 富田直秀ほか:生体内設計 (方法論としてのオートポイエティックマシン).骨関節靱帯17 (3):269-274, 2004
 
24) Harada Y, et al:Use of Controlled Mechanical Stimulation in Vivo to induce Cartilage Layer Formation on the Surface of Osteotomized Bone. Tissue Engineering 8 (6):969-978, 2002
 
25) Tomita N, et al:Reconstruction of Knee Joint Using Total Knee Regeneration System. Tissue Engineering for Therapeutic Use 6:41-49, 2002
 
26) 富田直秀:人工膝関節用ポリエチレンの耐久性次々世代人工膝関節の提案 (特集:TKAの手術成績を向上させるポイント). 関節外科:基礎と臨床19 (8):75-82, 2000
 
P.249 掲載の参考文献
1) 寿典子ほか:細胞プロセッシングセンターの実例-ティッシュエンジニアリング研究センター (TERC)-. 老年医:i:41:1837-1841, 2003
 
2) Kotobuki N, et al:Cultured autologous human cells for hard tissue regeneration:Preparation and characterization of mesenchymal stem cells from bone marrow. Artif Organs 28:33-39, 2004
PubMed
3) Muraki K, et al:Assessment of viability and osteogenic ability of human mesenchymal stem cells after being stored in suspension for clinical transplantation. Tissue Engineering (in press)
 
4) Kitamura S, et al:Osteogenic differentiation of human bone marrow-derived mesenchymal cells cultured on alumina ceramics. Artif Organs 28:72-82, 2004
PubMed
5) Kotobuki N, et al:Observation of osteogenic differentiation cascade of living mesenchymal stem cells on transparent hydroxyapatite ceramics. Biomaterials 26:779-785, 2005
PubMed
6) Kotobuki N, et al:Observation and quantitative analysis of rat mesenchymal stem cells cultured in vitro on newly formed transparent beta-tricalcium phosphate. Joumal of Materials Science;Materials in Medicile (in press)
 
7) http://www.jste.net/
 
8) Friedenstein AJ, et al:Heterotopic transplants of bone marrow. Analysis of precursor cells for osteogenic and haemopoietic tissues. Transplant 6:230-247, 1968
 
9) Owen M:Lineage of osteogenic cells and their relationship to the stromal system. Peck WA, ed:Bone and mineral research. Elsevier Science BV 3:1-25, 1985
 
10) Ohgushi H, et al:Osteogenic capacity of rat and human marrow cells in porous ceramics. Experiments in athymic (nude) mice. Acta Orthop Scand 61:431-434, 1990
PubMed
11) Jiang Y, et al:Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49, 2002
PubMed
12) Rubio D, et al:Spontaneous human adult stem cell transformation. Cancer Res 65:3035-3039, 2005
PubMed
13) Bardor M, et al:Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. J Biol Chem 280:4228-4237, 2005
 
14) Ohgushi H, et al:Tissue engineered ceramic artificial joint-Ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 22:4654, 2005
PubMed
P.252 掲載の参考文献
1) Newman AP:Articular cartilage repair. Am J Sports Med 26:309-324, 1998
PubMed
2) Mitchel N:The resurfacing of adult rabbit articular cartilage by multiple perforations through the subchondral bone. J one Joint Surg 58A:230-233, 1976
 
3) Stedman JR, et al:Microfracture:surgical technique and rehabilitation to treat chondral defects. Clin Orthop 391S:362-369, 2001
 
4) O:Driscoll SW, et al:The repair of major osteochondral defects in joints surfaces by neochondrogenesis with autogenous osteoperiosteal grafts stimulated by continuous passive motion:An experimental investigation in the rabbit. Clin Orthop 208:131-140, 1986
 
5) Ochi M, et al:Allogeneic deep frozen meniscal graft for repair of osteochondral defects in the knee joint. Arch. Orthop Trauma Surg 114:26-266, 1995
PubMed
6) Matsusue Y, et al:Arthroscopic multiple osteochondral transplantation to the chondral defect in the knee associated with anterior cruciate ligament disruption. Arthroscopy 7:312-322, 1993
 
7) Makino T, et al:Histologic analysis of the implantedted cartilage in an exact-fit osteochondral transplantation model. Arthroscopy 17:747-751, 2001
 
8) Brittberg M, et al:Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331:889-895, 1994
PubMed
9) Peterson L, et al:Two-to 9-year outcome after autologous chondrocytes transplantation of the knee. Clin Orthop 374:212-234, 2000
PubMed
10) Sohn DH, et al:Effect of gravity on localization of chondrocytes implanted in cartilage defects. Clin Orthop 394:254-262, 2002
PubMed
11) Ochi M, et al:Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defects of the knee. J Bone Joint Surg Br 84:571-857, 2002
PubMed
12) Ochi M, et al:Current concepts in tissue engineering technique for repair of cartilage defect. Artif Organs 25:172-179, 2001
PubMed
13) Uchio Y, et al:Arthroscopic assessment of human cartilage stiffness of the femoral condyles and the patela with a new tactile sensor. Med Eng Phys 24:431-435, 2002
 
14) Ito Y, et al:Repair of osteochondral defect with tissue-engineered chondral plug in a rabbit model. Arthroscopy (in press)
 
15) Pittenger MF, et al:Multilineage Potential of Adult Human Mesenchymal Stem Cells. Science 284:143-147, 1999
PubMed
16) Jiang Y, et al:Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41_49, 2002
 
17) Ochi M, et al:Articular cartilage repair using tissue engineering technique-novel approach with minimally invasive procedure. Artif Organs 28:28-32, 2004
PubMed

第15章 皮膚

P.258 掲載の参考文献
1) Green H, et al:Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA 76:5665-5668, 1979
PubMed
2) Hansbrough JF, et al:Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate. JAMA 262:2125-2130, 1989
PubMed
3) Kuroyanagi Y, et al:A cultured skin substitute composed of fibroblasts and keratinocytes with a collagen matrix; preliminary results of clinical trials. Ann Plast Surg 31:340-349, 1993
PubMed
4) Gentzkow GD, et al:Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 19:350-354, 1996
 
5) Hansbrough JF, et al:Clinical trials of a biosynthetic temporary skin replacement, Dermagraft-Transitional Coverage, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil 18:43-51, 1997
PubMed
6) 黒柳能光ほか:同種培養真皮の製造と供給システム (厚生科学再生医療ミレニアムプロジェクト). 日本熱傷学会誌29:28-38, 2003
 
7) Kuroyanagi Y, et al:Establishment of banking system for allogeneic cultured dermal substitute. Artif Organs 28:13-21, 2004
PubMed
8) Bell E, et al:Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 76:1274-1278, 1979
PubMed
9) Naughton G:The advanced tissue sciences story. Sci Amer 280:84-85, 1999
PubMed
10) Kubo K, et al:A study of cytokines released from fibroblasts in cultured dermal substitute. Artif Organs 29 (No. 10):2005 (in press)
 
11) Clark RAF:Overview and general considerations of wound repair. RAF Clark, PM Henson:The Molecular and cellular biology of wound repair. edn, Plenum Press, New York, p18-22, 1988
 
P.262 掲載の参考文献
1) Rochat A, et al:Location of stem cells of human hair follicles by clonal analysis. Cell 76:1063-1073, 1994
PubMed
2) Oshima H, et al:Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell 104:233-245, 2001
PubMed
3) Rheinwald JG, et al:Serial cultivation of strains of human epidermal keratinocytes:the formation of keratinizing colonies from single cells. Cell 6:331-343, 1975
PubMed
4) O'Connor NE, et al:Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1:75-78, 1981
 
5) Kumagai N, et al:Clinical application of autologous cultured epithelia for the treatment of burn wounds and bum scars. Plast Reconstr Surg 82:99-108, 1988
 
6) Oshima H, et al:Permanent, restoration of human skin treated with cultured epithelium grafting-wound healing by stem cell based tissue engineering-. Hum Cell 15:118-128, 2002
PubMed
7) Cuono C, et al:Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury. Lancet 1:1123-1124, 1986
 
8) Kopp J, et al:Applied tissue engineering in the closure of severe burns and chronic wounds using cultured human autologous keratinocytes in a natural fibrin matrix. Cell Tissue Bank 5:89-96, 2004
 
9) Horch RE, et al:Transplantation of cultured autologous keratinocytes in fibrin sealant biomatrix to resurface chronic wounds. Transplant Proc 33:642-644, 2001
PubMed
10) Kubo K, et al:Abstract Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts. J Artif Organs 6:138-144, 2003
 
11) 高見佳宏ほか:無細胞真皮マトリックスの性状と臨床応用. 日本熱傷学会誌26:261-267, 2000
 

第16章 感覚器・人工赤血球

P.266 掲載の参考文献
1) Chiu DT, et al:Autogenous vein graft as a conduit for nerve regeneration. Surgery 91 (2):226-233, 1982
 
2) Tang JB:Vein conduits with interposition of nerve tissue for peripheral nerve defects. J Reconstr Microsurg 11 (1):21-26, 1995
PubMed
3) Lawson GM, et al:Peripheral nerve reconstruction using freeze-thawed muscle grafts:a comparison with group fascicular nerve grafts in a large animal model. J R Coll Surg Edinb 43 (5):295-302, 1998
 
4) Dahlin LB:Use of tubes in peripheral nerve repair. Neurosurg Clin N Am 12 (2):341-352, 2001
PubMed
5) Pitta MC, et al:Use of Gore-Tex tubing as a conduit for inferior alveolar and lingual nerve repair:experience with 6 cases. J Oral Maxillofac Surg 59 (5):493-496, 2001
 
6) Mackinnon SE, et al:Aprimate model for chronic nerve compression. J Reconstr Microsurg 1 (3):185-195, 1985
 
7) Weber RA, et al:A randomized prospective study of polyglycolic acid conduits for digital nerve reconstruction in humans. Plast Reconstr Surg 106 (5):1036-1045, 2000
PubMed
8) 稲田有史ほか:人工神経による知覚神経欠損への臨床応用. 第21回日本運動器移植再生医学研究会 (2002.10.19東京)
 
9) 若林良明:末梢神経の再生と人工神経の開発. 第12回日本末梢神経学会学術集会02001)
 
10) Strauch B:Autologous Schwann cells drive regeneration through a 6-cm autogenous venous nerve conduit. J Reconstr Microsurg 17 (8):589-595, 2001
 
11) Kim DH, et al:Labeled Schwann cell transplants versus sural nerve grafts in nerve repair. J Neurosurg 80 (2):254-260, 1994
PubMed
12) Gulati AK:The influence of cultured Schwann cells on regeneration through acellular basal lamina grafts. Brain Res 24:705 (1-2):118-124, 1995
 
13) Koshimune M, et al:Creating bioabsorbable Schwann cell coated conduits through tissue engineering. Biomed Mater Eng 13 (3):223-229, 2003
PubMed
14) Komiyama T, et al:A novel technique to isolate adult Schwann cells for an artificial nerve conduit. J Neurosci Methods 122 (2):195-200, 2003
 
15) Kamada T, et al:Transplantation of bone marrow stromal cell-derived Schwann cells promotes axonal regeneration and functional recovery after complete transection of adult rat spinal cord. J Neuropathol Exp Neurol 64 (1):37-45, 2005
PubMed
P.273 掲載の参考文献
1) Mazzocco TM, et al:Soft implant lenses in cataract surgery, Slack, NJ. USA, 1986
 
2) アルパーフェヒナー, 山中昭夫監修:フェヒナー眼内レンズ. メディカル葵出版社, 東京,1987
 
3) 大鹿哲郎:小切開創白内障手術. 医学書院, 東京, 1994
 
4) 山中昭夫ほか:先端技術と企画 (ISO). 眼科の最先端, 先端医療技術研究所, 東京, p204-208, 1999
 
5) 横山雄一:HOYA黄色紫外線吸収型シングルピース眼内レンズ. 眼科の最先端, 先端医療技術研究所, 東京,p261-264, 1999
 
6) 佐藤道夫:先端技術のチェックシステム-インプラントデータシステムを例にして-. 眼科の最先端, 先端医療技術研究所, 東京,p209-214, 1999
 
7) 中村知昭:有水晶体眼内レンズ (Phakic IOL).眼科の最新医療, 先端医療技術研究所, 東京, p58-64, 2003
 
8) 安出 力:眼科ドラグデリバリーの進歩. 眼科の最新医療, 先端医療技術研究所,p128-136, 2003
 
9) 佐藤正樹:白内障手術の進歩. 眼科の最新医療, 先端医療技術研究所, 東京, p217-274, 2003
 
10) 長島晃彦:アクリルソフト眼内レンズアルコン「アクリソフ?」について. 眼科の最新医療, 先端医療技術研究所, 東京, p371-372, 2003
 
11) Fechner PU, et al:Worst-fechner bioconcave minus power phakic iris-claw lens. Journal of Refractive Surgevy 15:93-105, 1999
 
12) 山中昭夫ほか:眼内レンズインプラントデータシステム委員会活動報告 (第4報)-摘出眼内レンズの組織病理学的検討の活動報告 (1999年度)-.IOL&RS 15:58-61, 2001
 
13) 山中昭夫:眼科用生体材料. Practical ophthalmology 67, 文光堂,東京,2001
 
14) 早野三郎:我が国における眼内レンズとその手術の歩み. IOL&RS 16:2002
 
15) 山中昭夫:眼内レンズと眼内充填物 (人工硝子体). バイオマテリアル-生体材料-:228-240, 2002
 
16) 山中昭夫ほか:現代医療の最前線-人工臓器とメディカルエンジニアリングの進歩-. コンタクトレンズと眼内レンズ, 最新医学社,大阪,2003
 
P.278 掲載の参考文献
1) Kim JC, et al:Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 14:473-484, 1995
PubMed
2) Pellegrini G, et al:Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 349:990-993, 1997
PubMed
3) Koizumi N, et al:Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits. Cornea 19:65-71, 2000
 
4) Koizumi N, et al:Cultivated corneal epithelial transplantation for ocular surface reconstruction in acute phase of Stevens-Johnson syndrome. Arch Ophthalmol 119:298-300, 2001
PubMed
5) Koizumi N, et al:Cultivated corneal epithelial stem cell transplantation in ocular surface disorders. Ophthalmology 108:1569-1574, 2001
PubMed
6) 木下茂:眼の再生医学-Ocular Surface の再生. 日本眼科学会雑誌106:837-869, 2002
 
7) Kinoshita S, et al:Concept and Clinical aplication of cultivated epithelial transplantation for ocular surface disorders. The Ocular Surface 2:21-33, 2004
 
8) Nishida K, et al:Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surface. Transplantation 77:379-385, 2004
PubMed
9) Koizumi N, et al:Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest Ophthalmol Vis Sci 41:2506-2513, 2000
PubMed
10) Koizumi N, et al:An evaluation of cultivated corneal limbal epithelial cells, using cell-suspension culture. Invest Ophthalmol Vis Sci 43:2114-2121, 2002
PubMed
11) Nakamura T, et al:Successful primary culture and autologous transplantation of corneal limbal epithelial cells from minirrlal biopsy for unilateral severe ocular surface disease. Acta Ophthalmol Scand 82:468-471, 2004
PubMed
12) Nakamura T, et al:The successful culture and autologous transplantation of rabbit oral mucosal epithelial cells on amniotic membrane. Invest Ophthalmol Vis Sci 44:106-116, 2003
PubMed
13) Nakamura T, et al:Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders. Br J Ophthalmol 88:1280-1284, 2004
PubMed
14) Kinoshita S, et al:Transplantable cultivated mucosal epithelial sheet for ocular surface reconstruction. Exp Eye Res 78:483-491, 2004
PubMed
15) Nakamura T, et al:Sterilized, freeze-dried amniotic membrane:auseful substrate for ocular surface reconstruction. Invest Ophthalmol Vis Sci 45:93-99, 2004
 
P.285 掲載の参考文献
1) Kobayashi K, et al:Artificial Oxygen Carrier, Its Front Line. Springer-Verlag, Tokyo, 2005
 
2) Tsuchida E:Artificial Red Cells. Wiley, Chichester, 1998
 
3) Djordjevich L, et al:Lipid encapsulated hemoglobin as a synthetic elythrocyte. FASEB Proc 36:567, 1977
 
4) Sakai H, et al:Purification of concentrated hemoglobin using organic solvent and heat treatment. Protein Expr Purif 4:563-569, 1993
PubMed
5) Sou K, et al:Poly (ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly (ethylene glycol)-lipid into the vesicles. Bioconjugate Chem 11:372-379, 2000
 
6) Sakai H, et al:Poly (ethylene glycol)-conjugation and deoxygenation enable long-tenm preservation of hemoglobin-vesicles as oxygen carriers in a liquid state. Bioconjugate Chem 11:425-432, 2000
 
7) Sakai H, et al:Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemor-rhagic shock in anesthetized rats. Crit Care Med 32:539-545, 2004
 
8) Sakai H, et al:Acute 40%exchange transfusion with Hb-vesicles (HbV) suspended in recombinant HSA solution:Degradation of HbV and erythropoiesis in rat spleen observed for 2 Weeks. Transfusion (in press)
 
9) Sou K, et al:Circulation kinetics amd organ distribution of Hb-vesicles developed as a red blood cell substitute. J Pharmacol Exp Ther 312:702-709, 2005
 
10) Sakai H, et al:Hemoglobin-vesicles as oxygen carriers:Influence on phagocytic activity and histopathological changes in reticuloendothelial system. Am J Pathol 159:1079-1088, 2001
PubMed
11) Sakai H, et al:Physiologic capacity of reticuloendothelial system for degradation of hemoglobin-vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days. J Pharmacol Exp Ther 311:874-884, 2004
 
12) Sakai H, et al:Oxygen Releasing of Hb-vesicles with different P50s from Occluded Arteriole in Hamster Skinfold Window Model. Am J Physiol Heart Circ Physiol 288:H2897-H2903, 2005
 
13) Contaldo C, et al:New generation of hemoglobin-based oxygen carriers evaluated for oxygenation of critically ischemic hamster flap tissue. Crit Care Med 33:806-812, 2005
PubMed
14) Tsuchida E, et al:Human serum albumin incorporating tetrakis (o-pivalamido) phenylporphinatoiron (II) derivative as a totally synthetic O2-carrying hemoprotein. Bioconjugate Chem 10:797-802, 1999
 
15) Komatsu T, et al:Effect of heme structure on O2-binding properties of human serum albumin-heme hybrids:Intramolecular histidine coordination provides a stable O2-adduct complex. Bioconjugate Chem 13:397-402, 2002
 
16) Curry S, et al:Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding site. Nat Struct Biol 5:827-835, 1998
PubMed
17) Tsuchida E, et al:Human serum albumin incorporating synthetic heme:red blood cell substitute without hypertension by nitric oxide scavenging. J Biomed Mater Res 64A:257-261, 2003
 
18) Kobayashi K, et al:Oxygenation of hypoxia region in solid tumor by administration of human serum albumin incorporating synthetic hemes. J Biomed Mater Res 64A:48-51, 2003
 
19) Komatsu T, et al;Exchange transfusion with synthetic oxygen-carrying plasma protein "albumin-heme" into an acute anemia rat model after seventy-percent hemodilution. J Biomed Mater Res 71A:644-651, 2004
 
20) Komatsu T, et al:Physicochemical characterization of cross-linked human serum albumin dimer and its synthetic heme hybrid as an oxygen carrier. Biochim Biophys Acta 1675:21-31, 2004
PubMed
21) Zunszain P, et al:Crystal structural analysis of human serum albumin complexes with hemin and fatty acid. BMC Struct Biol 3:6, 2003
PubMed
22) Komatsu T, et al:Dioxygenation of human serum albumin having a prosthetic heme group in a tailor-made heme pocket. J Am Chem Soc 126:14304-14305, 2004
 

第17章 人工臓器を支える要素技術

P.291 掲載の参考文献
1) Kosaka R, et al:Online parameter identification of second-order systemic circulation model using the delta operator. Artif Organs 26:967-970, 2002
PubMed
2) Wang XZ, et al:Automatic monitoring system for artificial hearts using self organizing map. ASAIO J 47:686-691, 2001
PubMed
3) Wang XZ, et al:Automatic detection and classification of abnormalities for artificial hearts using a hierarchical self-organizing map. Artif Organs 25:150-153, 2001
PubMed
4) 田中 明ほか:完全置換型人工心臓の適応制御システムの開発. 人工臓器24:976-981, 1995
 
5) Matsuda H, et al:Current status of left ventricular assist devices:the role in bridge to heart transplantation and future perspectives. J Artif Organs 6:157-161, 2003
PubMed
6) 河野 智ほか:遠心ポンプによる差室脱血左室補助の有用性 (左房脱血との比較).人工臓器28:416-420, 1999
 
7) Takahashi K, et al:Estimation of left ventricular recovery level based on the motor current waveform analysis on circulatory support with centrifugal blood pump. Artif Organs 25:713-718, 2001
PubMed
8) Nitta S, et al:Aless invasive Emax estimation method for weaning from cardiac assistance. IEEE Trans Biomed Eng 42:1165-1173, 1995
 
9) Yambe, et al:Totally implantable ventricular assist system that can increase brain blood flow. Artif Organs 24:644-647, 2000
PubMed
10) 産経新聞「未来史閲覧」取材班編:未来史閲覧健康生活編. 扶桑社. 文庫, 東京, 1999
 
P.295 掲載の参考文献
1) Manz A, et al (eds):Microsystem Technology in chemistry and life science. Springer-Verlag, Berlin, 1998
 
2) 高分子学会編:微細加工技術, エヌ・ティーエス, 2002
 
3) Maruyama N, et al:Thin Solid Films, Mesoscopic Patterns of Molecular Aggregates on Solid. Substrates 854:327-329, 1998
 
4) Karthaus O, et al:Water-Assisted Formation of Micrometer-size Honeycomb Patterns of Polymers. Langmuir 16:6071, 2000
 
5) Nishikawa T, et al:Fabrication of Honyecomb Film of an Amphiphilic Copolymer at the Air-Water Interface. Langmuir 18:5734, 2002
 
6) Sato K, et al:Preparation of the honeycomb patterned film of biodegradable polynier for tissue engineering scaffolds. Int J Nanosci 1 (5-6):689, 2002
 
7) Tanaka M, et al:Design of novel biointerfaces (II). Fabrication of self-organized porous polymer film with highly uniform pores. Bio-Med Mater Eng 14:439, 2004
PubMed
8) 田中 賢ほか:自己組織化パターン表面の創製と機能第1編第8章バイオナノエンジニアリングマテリアル, p72-84, 2004
 
9) Yabu H, et al:Preparation of Honeycomb-Patterned Polyimide Films by Self-Organization. Langmuir 19:6297, 2003
 
10) Yabu H, et al:Super Hydrophobic and Lipophobic Properties of Self-Organized Honeycomb and Pincushion Structures. Langmuir 21:3235, 2005
 
11) Tsuruma A, et al:Morphological changes in neurons by self-organized patterned films. E-J. Surf Sci Nanotech 3:159, 2005
 
12) 鶴間章典ほか:高分子の自己組織化パターンによる神経細胞の形態変化. 高分子論文集61:628, 2004
 
13) Tanaka M, et al:Study of Blood Compatibility with Pory (2-methoxyethyl acrylate). Relationship between Water Structure and Platelet Compatibility in Poly (s-methoxyethy-lacrylate-co-2-hydroxyethylmethacrylate). Biomacromolecules 3:36, 2002
 
14) Tanaka M, et al:Effect of water structure on blood compatibility-Thermal analysis of water in poly (meth) acrylate.-J Biomed Mater Res 68A:684, 2004
 
P.300 掲載の参考文献
1) 青木秀希:アパタイト. 医歯薬出版株式会社, 東京,1999
 
2) Wang M, et al:Hydroxyapatite-polyethylene composites for bone substitution:effects of ceramic particle size and morphology. Biomaterials 19:2357-2366, 1998
 
3) Kikuchi M, et al:Self-organization mechanism in a bone-like hydroxyapatite/collagen nanocomposite synthesized invitro and its biological reaction in vivo. Biomaterials 22:1705-1711, 2001
 
4) Tanahashi M, et al:Apatite coating on organic polymer by biomimetic prpocess. J Am Ceram Soc 77:2805-2808, 1994
 
5) Taguchi T, et al:Hydroxyapatite formation on/in poly (vinyl alcohol) hydrogel matrices using a novel alternated soaking process. Chem Lett:711-712, 1998
 
6) Furuzono T, et al:Nano-scaled hydroxyapatite/polymer composite I. Coating of sintered hydroxyapatite particles on poly (ganna-methacryloxypropyl trimethoxysilane) grafted silk fibroin fibers through chemical bonding. J Mater Sci Mater Med 15:19-23, 2004
 
7) Furuzono T, et al:Nano-scaled hydroxyapatite/composite W. Fabrication and cell adhesion properties of a three-dimensional scaffold made of compsite material with a silk fibroin substrate to develop a percutaneous device. J Artif Organs 7:137-144, 2004
 
8) Sonoda K, et al:Influence of emulsion on crystal growth of hydroxyapatite. Solid State Ionics 151:321-327, 2002
 
9) Okada M, et al:Fabrication of high-dispersibility nanocrystals of calcinated hydroxyapatite. Nanotechnology (in contribution)
 
10) Kawasaki K:Hydroxyapatite as a liquid chromatographic packing. J Chromatogr 544:147-184, 1991
 
11) Furuozno T, et al:Increase of cell adhesiveness on oly (ethylene terephtalate) fabric by coating of sintered hydroxyapatie nanocrystals for development of an artificial blood vessel. ASAIO Journal (in contribution)
 
12) Midy V, et al:Basic fibroblast growth factor adsorption and release properties of calcium phosphate. J Biomed Mater Res 56:9-16, 2001
 
13) Amino S, et al:Cell attachment and spreading factors of human periodontal ligament fibroblasts. Bull. Lanagawa Dent Col 27:179-192, 1992
 
P.305 掲載の参考文献
1) 石原一彦ほか:バイオマテリアルサイエンス.東京化学同人, 東京,2003
 
2) 石原一彦監修:ナノバイオマテリアルエンジニアリング. フロンティア出版,東京,2004
 
3) 石原一彦:細胞膜に着目した体に適合しやすい材料-リン脂質ポリマーバイオマテリアル.現代化学2004 (8):49-54, 2004
 
4) Watanabe J, et al:Biointerface, biocoajugation, and biomatrix based on bioinspired phospholipid polymers. Handbook of Nanostructured Biomaterials and Their Applications in Nanobiotechnology, American Scientific Publishers, San Diego, p129-165, 2005
 
5) Sawada S, et al:Suppression of inflammatory response from adherent cells on phospholipid polymers. J Biomed Mater Res 64A:411-416, 2003
 
6) Ishihara K, et al:Why do phospholipid polymers reduce protein adsorption? J Biomed Mater Res 39:323-330, 1998
PubMed
7) Ishihara K, et al:Inhibition of cel adhesion on the substrate by coating with 2-methacryloyloxyethylphosphorylcholine polymers, J Biomater Sci Polymer Edn 10, 1047-1061, 1999
 
8) 北野博巳ほか:高分子-水界面水の構造解析からのアプローチ-. 高分子 52:28-33, 2003
 
9) 石原一彦ほか:高精度バイオ検査を実現する表面処理技術-PCサーフェイステクノロジーの応用-. 検査技術10 (7):12-18, 2005
 
10) Myers GJ, et al:Evaluation of mimesys phosphorylcholine (PC)-coated oxygenators during cardiopulmonary bypass in adults. J Extra Corpor Technol 35 (1):6-12, 2003
PubMed
11) 石原彦:バイオマテリアルイノベーション-世界最小口径人工血管を実現するマテリアル-. 化学と工業57 (10):1071-1073, 2004
 
12) Ye SH, et al:Design of functional hollow fiber membranes modified with phospholipid polymers for application in total hemopurification system. Biomaterials 26 (24):5032-5041, 2005
PubMed
13) Ishihara K, et al:Biocompatible phospholipid polymers for prevention of unfavorable bioreactions on the surface of medical devices. Biomedical Diagnostic Science and Technology, American Chemical Society, Washington DC, p367-379, 2002
 
14) Moro T, et al:Surface grafting of artificial joints with a biocompatible polymer for preventing periprosthetic osteolysis. Nature Materials 3 (11):829-836, 2004
PubMed
15) Andrews CS, et al:A Comparison of the use of an ATP-based bioluminescent assay and image analysis for the assessment of bacterial adhesion to standard HEMA and biomimetic soft contact lenses. Biomaterials 22:3225-3233, 2001
PubMed

第18章 再生医療の基盤技術

P.311 掲載の参考文献
1) Chen G, et al:Scaffold Design for Tissue Engineering. Macromole Biosci 2:67-77, 2002
 
2) Chen G, et al:Preparation of Poly (L-Lactic Acid) and Poly (DL-Lactic-co-Glycolic Acid) Foams by Use of Ice Microparticulates. Biomaterials 22:2563-2567, 2001
PubMed
3) Chen G, et al:Hybrid Biomaterials for Tissue Engineering:A Preparative Method of PLA or PLGA-Collagen Hybrid Sponge. Adv Mater 12:455-457, 2000
 
4) Chen G, et al:A Biodegradable Hybrid Sponge Nested with Collagen Microsponges. J Biomed Mater Res 51:273-279, 2000
 
5) Chen G, et al:A Hybrid Network of Synthetic Polymer Mesh and Collagen Sponge. Chem Commun 16:1505-1506, 2000
 
6) Chen G, et al:Poly (DL-lactic-co-glycolic acid) Sponge Hybridized with Collagen Microsponges and Deposited Apatite Particulates. J Biomed Mater Res 57:8-14, 2001
PubMed
7) Chen G, et al:Culturing of Skin Fibroblasts in a Thin PLGA-Collagen Hybrid Mesh. Biomaterials 26:2559-2566, 2005
 
8) Chen G, et al:Application of PLGA-collagen Hybrid Mesh for Three-dimensional Culture of Canine Anterior Cruciate Ligament Cells. Mat Sci Eng C-Bio S 24:861-866, 2004
 
9) Chen G, et al:Redifferentiation of Dedifferentiated Bovine Chondrocytes when Cultured in vitro in a PLGA-Collagen Hybrid Mesh. FEBS Lett 542:95-99, 2003
 
10) Chen G, et al:The Use of a Novel PLGA Fiber/Collagen Composite Web as a Scaffold for Engineering of Articular Cartilage Tissue With Adjustable Thickness. J Biomed Mater Res 67:1170-1180, 2003
 
11) Chen G, et al:Chondrogenic Differentiation of Human Mesenchymal Stem Cells Cultured in a Cobweb-like Biodegradable Scaffold. Biochem Biophys Res Commun 322:50-55, 2004
 
12) Chen G, et al:Tissue Engineering of Cartilage Using a Hybrid Scaffold of Synthetic Polymer and Collagen. Tissue Eng 10:323-330, 2004
PubMed
13) Tsuchiya K, et al:Establishment of a Custom-Shaping System for Bone Regeneration by Seeding Marrow Stromal Cells onto a Web-like Biodegradable Hybrid Sheet. Cell Tissue Res 316:141-153, 2004
 
14) Iwai S, et al:Biodegradable Polymer with Collagen Microsponge Serves as a New Bioengineered Cardiovascular Prosthesis. J Thorac Cardiovasc Surg 128:472-479, 2004
PubMed
15) Ochi K, et al:Use of Isolated Mature Osteoblasts in Abundance Acts as Desired-Shaped Bone Regeneration in Combination with a Modified Poly-DL-Lactic-co-Glycolic Acid (PLGA)-Colagen Sponge. J Cell Physiol 194:45-53, 2003
 
P.316 掲載の参考文献
1) Shimizu T, et al:Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 24:2309-2316, 2003
PubMed
2) Yamada N, et al:Thermo-responsive polymeric surfaces; control of attachment and detachment of cultured cells Makromol Chem Rapid Com 11:571-576, 1990
 
3) Okano T, et al:A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly (Nisopropylacrylamide). J Biomed Mater Res 27:1243-1251, 1993
 
4) Yamato M, et al:Signal transduction and cytoskeletal reorganization are required for cell detachment from cell culture surfaces grafted with a temperature-responsive polymer. J Biomed Mater Res 44:44-52, 1999
PubMed
5) Shimizu T, et al:Two-dimensional manipulation of cardiac myocyte sheets utilizing temperature-responsive culture dishes augments the pulsatile amplitude. Tissue Eng 7:141-151, 2001
PubMed
6) Kushida A, et al:Decrease in culture temperature releases monolayer endothelial cell sheets together with deposited fibronectin matrix from temperature-responsive culture surfaces. J Biomed Mater Res 45:355-362, 1999
PubMed
7) Yamato M, et al:Thermo-responsive culture dishes allow the intact harvest of multilayered keratinocyte sheets without dispase by reducing temperature. Tissue Eng 7:473-480, 2001
PubMed
8) Nishida K, et al:Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium N Engl J Med 351:1187-1196, 2004
PubMed
9) Hasegawa M, et al:Human periodontal ligament cell sheets can regenerate periodontal ligament tissue in an athymic rat model. Tissue Eng 11:469-478, 2005
 
10) Shiroyanagi Y, et al:Urothelium regeneration using viable cultured urothelial cell sheets grafted on demucosalized gastric fiaps. BJU Int 93:1069-1075, 2004
 
11) Shimizu T, et al:Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90:e4048, 2002
 
12) Harimoto M, et al:Novel approach for achieving double-layered cell sheets co-culture:overlaying endothelial cell sheets onto monolayer hepatocytes utilizing temperature-responsive culture dishes. J Biomed Mater Res 62:464-470, 2002
PubMed
13) Ogawa K, et al:The generation of functionally differentiated, three-dimensional hepatic tissue from two-dimensional sheets of progenitor small hepatocytes and nonparenchymal cells. Transplantation 77:1783-1789, 2004
PubMed
14) Itabashi Y, et al:Anew method for manufacturing cardiac cell sheets using fibrin-coated dishes and its electrophysiological studies by optical mapping. Artif Organs 29:95-103, 2005
 
15) Tsuda Y, et al:The use of pattemed dual thermoresponsive surfaces for the collective recovery as co-cultured cell sheets. Biomaterials 26:1885-1893, 2005
PubMed
P.320 掲載の参考文献
1) Uchimura E, et al:Novel method of preparing acellular cardiovascular grafts by decellularization With poly (ethylene glycol). J Biomed Mater Res 67A:834-837, 2003
 
2) 岩崎清隆ほか:無細胞異種大動脈弁の開発:脈動循環下でのマイクロ波照射による脱細胞化と脈動バイオリアクタを用いての前内皮化.人工臓器32:S70, 2003
 
3) 藤里俊哉ほか:超高圧処理による脱細胞化生体組織. 人工臓器33:S134, 2004
 
4) Haverich A, et al:Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 14:279-284, 1998
PubMed
5) 尾崎重之ほか:人工弁の最近の進歩. バイオマテリアル22:89-98, 2004
 
6) Iwai S, et al:Biodegardable polymer with collagen microsponge sereves as a new bioengineered cardiovascular prosthesis. J Thorac Cardiovasc Surg 128:472-479, 2004
 
7) Ota T, et al:Fibronectin-hepatocyte growth factor enhances reendothelialization in tissue-engineered heart valve. Ann Thorac Surg in press, 2004
 
8) Simon P, et al:Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 23:1002-1006, 2003
PubMed
9) Dohmen P, et al:Ross operation with a tissue-engineered heart valve. Ann Thorac Surg 74:1438-1442, 2002
PubMed
P.324 掲載の参考文献
1) Thomas CH, et al:Surfaces designed to control the projected area and shape of individual cells. J Biomech Eng 121:40-48, 1999
 
2) Xia Y, et al:Soft lithography. Angew Chem lnt Ed 37:550-575, 1998
 
3) Chen CS, et al:Geometric control of cell life and death. Science 276:1425-1428, 1997
PubMed
4) Singhvi R, et al:Engineering cell shape and function. Science 264:696-698, 1994
PubMed
5) Folch A, et al:Molding of deep polydimethylsiloxane microstructures for microfluidics and biological applications. J Biomech Eng 121:28-34, 1999
PubMed
6) Langer R, et al:Tissue engineering. Science 260:920-926, 1993
PubMed
7) Bhatia SN, et al:Controlling cell interactions by micropatterning in co-cultures:Hepatocytes and 3T3 fibroblasts. J Biomed Mater Res 34:189-199, 1997
PubMed
8) Moriguchi H, et al:An agar-microchamber cell-cultivation system:flexible change of microchamber shapes during cultivation by photo-thermal etching. Lab Chip 2:125-130, 2002
PubMed
9) Suzuki I, et al:Stepwise pattern modification of neuronal network in photo-thermallyetched agarose architecture on multi-electrode array chip for individualcell-based electrophysiological measurement. Lab Chip 5:241-247, 2005
PubMed
10) Kojima K, et al:Two-dimensional network formation of cardiac myocytes in agar microculture chip with 1480 nm infrared laser photo-thermal etching. Lab Chip 3:292-296, 2003
PubMed
11) Kojima K, et al:Stability of beating frequency in cardiac myocytes by their community effect measured by agarose microchamber chip. J Nanobiotechnol 3:4, 2005
 
12) Powers MJ, et al:Amicrofabricated array bioreactor for perfused 3D liver culture. Biotechnol Bioeng 78:257-269, 2002
PubMed
13) Leclerc E, et al:Microfluidic PDMS (polydimethylsiloxane) bioreactor for large-scale culture of hepatocytes. Biotechnol Prog 20:750-755, 2004
PubMed
14) Tsuda Y, et al:The use of patterned dual thermoresponsive surfaces for the collective recovery as co-cultured cell sheets. Biomaterials 26:1885-1893, 2005
PubMed
15) Itoga K, et al:Cell micropatterning using photopolymerization with a liquid crystal device commercial projector. Biomaterials 25:2047-2053, 2004
PubMed

第19章 人工臓器・再生医療の臨床応用に向けた環境整備

P.329 掲載の参考文献
1) 特許庁:特許実用新案審査基準. 第II部第1章産業上利用することができる発明
 
2) 特許庁:特許実用新案審査基準. 第VII部第3章医薬発明
 

技術資料編

P.335 掲載の参考文献
1) 渡辺 直ほか:大動脈内バルーンパンピング (IABP) 使用に際しての下肢虚血防止法. ICUと CCU 21:799-806, 1997
Medical*Online
2) 吉岡幸男ほか:日本人の体格に適した大動脈内バルーンのサイズの検討. 人工臓器17:960-963, 1988
 
3) 筒井宣政ほか:高性能IABPカテーテルの開発. 生体材料15:71-76, 1997
 
4) 森 謙二ほか:IABPバルーンカテーテルの細径化の検討. 循環器科51:471-473, 2002
 
5) 関野美仁ほか:鎖骨下動脈からのIABPカテーテル挿入の経験. 循環器科41:189-190, 1997
 
6) 渡辺 弘ほか:小児用IABPバルーンカテーテルの開発. 人工臓器24:251-255, 1995
 
P.337 掲載の参考文献
1) Guyton RA, et al:Postcardiotomy Shock:Clinical Evaluation of the BVS 5000 Biventricular Support System. Ann Thorac Surg 56:346-356, 1993
PubMed
2) 後藤昌弘ほか:人工心房とポリウレタン製人工弁を有する補助人工心臓ABIOMED社製BVSシステム5000の実験的検討. 人工心臓20 (3):806-810, 1991
 
3) 里学ほか:ABIOMED(R)BVS5000(R)を臨床使用した3例. 日本胸部外科学会雑誌46:236-242, 1998
 
4) 里学ほか:補助人工心臓 "ABIOMED" 社製 BVS5000による劇症型心筋炎の治療経験. 胸部外科51:451-456, 1998
 
P.343 掲載の参考文献
1) 糖尿病足病変に関するワーキンググループ編/中村 功, 渥美義仁監訳:インターナショナルコンセンサス糖尿病足病変. 医歯薬出版,東京, p35-43, 2000
 
2) 太田 敬:目的別血行力学的検査.Progress in Medicine 22 (12):3027-3032, 2002
Medical*Online
3) 杉本郁夫ほか:慢性動脈閉塞症に対する症候別の無侵襲診断法.JJpn Coll Angiol 43 (7):297-301, 2003
 
4) 重松 宏ほか:皮膚組織灌流圧.JJpn Coll Angiol 45 (5):294-298, 2005
 
5) Transatlantic Inter-Society Consensus (TASC) Working Group:Management of Peripheral Arterial Disease (PAD). J Vasc Surg 31, 2000
 
6) Dwars BJ, et al:Criteria for reliable selection of the lowest level of amputation in peripheral vascular disease. J Vasc Surg 15 (3):536-542, 1992
PubMed
7) Adera HM, et al:Prediction of amputation wound healing with skin perfusion pressure. J Vasc Surg 21 (5):823-828; discussion 828-829, 1995
 
8) 寺師浩人ほか:重症虚血肢の診断治療におけるレーザードップPV2000の有用性-Skin Perfusion Pressure (SPP,皮膚灌流圧) 測定の意義について. Jpn J PIast Reconstr Surg 48 (8):901-909, 2005
 
9) Holstein P, et al:Skin perfusion pressure measured as the external pressure required to stop isotope washout. Methodological considerations and normal values on the legs. Scand J Clin Lab Invest 37 (7):649-659, 1977
PubMed
10) Castronuovo JJ Jr, et al:Noninvasive determination of skin perfusion pressure using a laser Doppler. J Cardiovasc Surg (Torino) 28 (3):253-257, 1987
 
11) Malvezzi L, et al:The correlation between three methods of skin perfusion pressure measurement:Radionuclide washout, laser Doppler flow, and photoplethysmography. J Vasc Surg 15 (5):823-829;discussion 829-830, 1992
 
12) Parmiter S, et al:The reproducibility of laser Doppler skin perfusion pressure measurements (Abstract). J Vasc Tech 17:208, 1993
 
13) Castronuovo JJ Jr, et al:Noninvasive determination of skin perfusion pressure using a laser Doppler. J Cardiovasc Surg (Torino) 28 (3):253-257, 1987
 
14) Tsai FW, et al:Skin perfusion pressure of the foot is a good substitute for toe pressure in the assessment of limb ischemia. J Vasc Surg 32 (1):32-36, 2000
PubMed
15) Castronuovo JJ Jr, et al:Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia. J Vasc Surg 26 (4):629-637, 1997
 
16) Ubbink DT, et al:Prediction of imminent amputation in patients with non-reconstructible leg ischemia by means of microcirculatory investigations. J Vasc Surg 30 (1) 1114-121, 1999
 
17) Kanetaka T, et al:Usefulness of skin perfusion pressure measurement in evaluation of ischemic lower limb, Breakthrough in The Treatment for Critical Limb Ischemia in Japan, Japanese Society for Limb Salvage Research, p29-34, 2004
 
18) 兼高武仁ほか:Skin perfusion pressureを用いた Buerger病の肢虚血重症度評価. 難治性血管炎に関する調査研究. 平成14年度総括研究報告書厚生科学研究費補助金 (特定疾患対策研究事業) 担研究報告書:67-70, 2003
 
19) Kanetaka T, et al:Laser Doppler Skin Perfusion Pressure in the Assessment of Raynaud's Phenomenon. Eur J Vasc Endovasc Surg 27:414-416, 2004
 
P.347 掲載の参考文献
1) Ely JL, et al:Pure pyrolytic carbon:Preparation and properties of a new material-On-X carbon for medical heart valve prostheses. J Heart Valve Dis 7:626-632, 1998
PubMed
2) Ma L, et al:Fatigue of isotropic pyrolytic carbon used in mechanical heart valves. J Biomed Master Res 5 (suppl.1):S59-64, 1996
 
3) Ma L, et al:Unalloyed pyrolytic carbon for implanted mechanical heart valves. J Heart Valve DIs 8 (5):575-585, 1999
 
4) Ma L:Studies on pyrolytic carbons for biomedical applications. PhD dissertation. University of Califomia, Los Angeles, p241, 1997
 
5) Summary of Safety and Effectiveness, On-X(R) Prosthetic Heart Valve, Food and Drug Administration PMA P000037, May 30, 2001;P000037/S 1, March 6, 2002;Primary European Trial, updated May 31, 2003
 
6) Birnbaum D, et al:Examination of hemolytic potential with the On-X(R)Prosthetic Heart Valve J Heart Valve Dis 9 (1):142-145, 2000
PubMed
7) Williams MA, et al:The On-X valve-results at four years in a poorly anticoagulated population. Presented at 12th Annual Meeting of the Asian Society for Cardiovascular Surgery, April, Istanbul, Turkey, p 19-22, 2004
 
8) Mehlhorn U, et al:The On-X mechanical heart valve prosthesis aspirin-only trial:Preliminary results at up to 16 months follow-up. 15th World Society of Cardio-Thoracic Surgeons. June, Vilnius, Lithuania, p 19-23, 2005
 
9) Philips SJ:Searching for the truth:a mechanical or a tissue valve? J Heart Valve Dis 13 (Suppl. 1):S95-98, 2004
 
10) Grunkemeier GL, et al:Long-term perfornance of heart valve prosthesis. Curr Probl Cardiol 25:73-156, 2000
PubMed
11) Wheatley D:The "Threshold Age"in choosing biological versus mechanical prostheses in westem countries. J Heart Valve Dis 13 (Suppl 1):S91-94, 2004
 
12) Novoa R, et al:Prevalence of patient-prosthesis mismatch in a community hospital. Medical Carbon Research Institute, LLC, Austin, Innovations in Cardiac Surgery27, 2003
 
P.349 掲載の参考文献
1) Ovrum E, et al:Acute Leaflet arrest in St. Jude Medical Regent aortic valve. J Thorac Cardiovasc Surg 129:1446, 2005
 
2) 幕内晴朗ほか:狭小弁輪に対する大動脈弁置換術の実際. パンフレット
 
3) Campbell A, et al:Development of an Ascending Aortic Valved Conduit. 人工臓器21:625-634, 1992
 
4) 大内 浩ほか:人工血管付機i械弁 (Carbo-Seal) の使用経験. 人工臓器29:105-108, 2000
 
P.351 掲載の参考文献
1) Carpentier-Edwards Perimount Aortic Pericardial Bioprosthesis 20-year Results. Data on file at Edwards Lifesciences, 2003
 
2) Broom ND, et al:Influence of fixation condition on the performance of glutaraldehyde-treated porcine aortic valves:towards a more scientific basis. Thorax 34:166-176, 1979
 
3) Mayne ASD, et al:An assessment of the mechanical properties of leaflets from four second-generation porcine bioprostheses with biaxial testing technique. J Thorac Cardiovasc Surg 98:170-180, 1989
 
4) Data on file at Edwards Lifesciences
 
5) Cunanan C, et al:Tissue Characterization and calcification potential of commercial bioprosthetic heart valves. Ann Thorac Surg 71:S417-421, 2001
PubMed
6) Jin Y, et al:Performance of Edwards Prima stentless aortic valve over eight years. Semin Thorac Cardiovasc Surg 13:S163-167, 2001
 
7) Nakajima, et al:Twelve-year experience with the 19mm Carpentier-Edwards pericardial aortic valve. J Heart Valve Dis 7:534-539, 1998
 
8) Marchand, et al:Fifteen-year Experience with the mitral Carpentier-Edwards Perimount pericardial bioprsthesis. Ann Thorac Surg 71:S236-239, 2001
PubMed
P.354 掲載の参考文献
1) 新井達太:XII人工弁, 新井達太:心臓弁膜症の外科第2版, 医学書院, 東京, p551-601, 2003
 
2) Jamieson WRE, et al:Carpentier-Edwards Standard and Supraannular Porcine Bioprostheses:Comparison of Technology. Ann Thorac Surg 67:10-17, 1999
 
3) Jamieson WRE, et al:Hemodynamic Comparison of Second-and Third-Generation Stented Bioprostheses in Aortic Valve Replacement. Ann Thorac Surg 71:S282-284, 2001
 
4) Schoen F, et al:Tissue Heart Valves:Current Challenges and Future Research Perspectives. J Biomed Mater Res 47:439-465, 1999
PubMed
5) Schoen F, et al:Calcification of Tissue Heart Valve Substitutes:Progress Toward Understanding and Prevention. Ann Thorac Surg 79:1072-1080, 2005
PubMed
6) Sack MS, et al:The aortic valve microstructure:Effects of transvalvular pressure. J Biomed Mater Res 41:131-141, 1998
 
7) Cunanan CM, et al:Tissue Characterization and Calcification Potential of Commercial Bioprosthetic Heart Valves. Ann Thorac Surg 71:S417-421, 2001
PubMed
8) Chen W, et al:Mechanism of Efficacy of 2-Amino Oleic Acid for Inhibition of Calcification of Glutaraldehyde-Pretreated Porcine Bioprosthetic Heart Valves. Circulation 90:323-329, 1994
PubMed
9) Gott JP, et al:Refinement of the Alpha Aminooleic Acis Bioprosthetis Valve Anticalicification Technique. Ann Thorac Surg 64:50-58, 1997
 
10) Herijgers P, et al:Calcification characteristics of porcine stentless valves in juvenile sheep. Eur J Cardio-thorac Surg 15:134-142, 1999
 
11) Flameng W, et al:Antimineralization Treatment in Stentless Porcine Bioprostheses:An Experimental Study. J Heart Valve Dis 10 (4):489-494, 2001
PubMed
12) Neethling WML, et al:Kangaroo Versus Freestyle Stentless Bioprostheses in a Juvenile Sheep Model:Hemodynamic Performance and Calcifi-cation Behavior. J Card Surg 20:29-34, 2005
 
13) Melina G, et al:A quantitative study of calcium deposition in the aortic wall following Medtronic Freestyle compared with homograft aortic root. J Heart Valve Dis 9 (1):97-103, 2000
 
14) Melina G, et al:Electron Beam Tomography for Cusp Calcification in Homograft Versus Freestyle Xenografts. Ann Thorac Surg 71:S368-370, 2001
PubMed
15) Melina G, et al:Three-dimensional in vivo characterization of calcification in native valves and in Freestyle versus homograft aonic valves. J Thorac Cardiovasc Surg 130:41-47, 2005
PubMed
16) Melina G, et al:Homograft versus Medtronic Freestyle Full Aortic Root Replacement. Five-Year Follow-up from a Prospective Randomized Trial. Abstract from session Bioprosthetic valves H of the Society for Heart Valve Disease 2nd Biennial Meeting 2003
 
17) Eichinger W, et al:The Mosaic bioprosthesis in the aortic position at five years. J Heart Valve Dis 9 (5):653-660, 2000
PubMed
P.359 掲載の参考文献
1) 大西誠人ほか:ポリ (2-メトキシエチルアクリレート) よりなる新しい血液適合性表面. 人工臓器 22:S62, 1998
 
2) 安斎崇王ほか:ポリ2メトキシエチルアクリレートをコートした人工肺のIn Vitro生体適合性評価. 人工臓器29:73-79, 2000.
 
3) Zimmermann AK, et al:Hemocompatibility of PMEA Coated Oxygenators Used for Extracorporeal Circulation Procedures. ASAIO Journal 50:193-199, 2004
PubMed
4) 田山栄基:体外循環の病態生理.体外循環と補助循環, 日本人工臓器学会,p3543, 2005
 
5) 望月 明ほか:抗血栓性バイオマテリアル. BIO INDUSTRY 18:48-58, 2001
 
6) Hazlewood CF, et al:Evidence for the existence of a minimum of two phases of ordered water in skeletal muscle. Nature 222:747-748, 1969
PubMed
7) Uedaira H:Water and Metal Cations in Biological Systems, Pullman B, Yagi K, Eds. Japan Scientific Societies Press, Tokyo, P47-56, 1980
 
8) 渡邉文亮ほか:PMEAコーティング回路を用いた体外循環下開心術における生体適合性についての検討. 人工臓器30:S72, 2001
 
9) 武島智隆ほか:臨床におけるXコーティングの血液適合性評価. 体外循環技術29:398-400, 2002
 
10) 黒光弘幸ほか:ポリ2メトキシエチルアクリレートコーティングの臨床使用評価. 体外循環技術 29:112-115, 2002
Medical*Online
11) Gunaydin S, et al:Clinical Perforrnance and Biocompatibility of Poly (2-methoxyethylacrylate)-Coated EXtracorporeal Circuits. Ann Thorac Surg 74:819-824, 2002
PubMed
12) Vang SN, et al:Clinical evaluation of poly (2-methoxyethylacrylate) in primary coronary artery bypass grafting. J Extra Corpor Technol 37:23-31, 2005
PubMed
P.361 掲載の参考文献
1) 小西 淳ほか:自己組織を構築させる新タイプのコラーゲン材料. 人工臓器18:155-158, 1989
 
2) M Koide, et al:A new type of biomaterial for artificial skin. Biomed Mater Res 27:79-87, 1993
 
3) 中村雄幸ほか:人工真皮SS-Dの皮膚全層欠損部使用例の検討. 熱傷22:25-33, 1996
 
P.367 掲載の参考文献
1) Van Woermsen J, et al:ANS controlled Closed Loop cardiac pacing-A multicenter study. Progress in Biomedical Research 1 (1):13-16, 1996
 
2) Pichelmaier AM, et al:A multicenter study of a Closed-Loop ANS-controlled pacemaker system. Pace 16:1930, 1993
 
3) Res JCJ, et al:Dual chamber pacing and Closed-Loop regulation-Clinical results. Progress in Biomedical Research 1 (2):27-30, 1996
 
4) Lau CP:Rate adaptive cardiac pacing:Single and Dual Chamber. Futura Publishing Company, New York:1993
 
5) Hutten H, et al:Rate-adaptive cardiac pacing considering Closed-Loop control. Proceedings of the Annual Int. Conf. Of the IEEE Eng. in Med. and Biology Society 13:2111-2113, 1991 (原著:M. Schaldach, PhD. 邦訳:石田稔 Progress in Biomedical Research Vol.3, No. 2, 1998
 
P.375 掲載の参考文献
1) 正岡勝則, 藤井健一:安全性向上に向けた工夫. 日本臨牀 62 (増刊号5):105-108, 2004
Medical*Online
2) 峰島三千男:ダイアライザにおける内部濾過発生のメカニズム. 臨床透析18:391-396, 2002
 
3) 山下明泰:in vitro 評価による内部濾過促進型ダイアライザの溶質除去特性. 臨床透析18:397-401, 2002
 
4) 佐藤雄一:超音波を利用したダイアライザ内部濾過流量実測の試み. 臨床透析18:429-433, 2002
 
5) 金 成泰:二次汚染防止のための水処理の基本原則透析液水質管理&オンラインHDF. メディカルレビュー社,p87-89, 1996
 
P.378 掲載の参考文献
1) 土肥俊之ほか:平成14年度膜型人工肺アンケート調査結果. 膜型肺26:8-12, 2002
 
P.382 掲載の参考文献
1) Fujii S, et al:New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin. Biochim Biophys Acta 661:342-345, 1981
PubMed
2) Hitomi Y, et al:Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system. Haemostasis 15:164-168, 1985
PubMed
3) Ikari N, et al:New synthetic inhibitor to the alternative complement pathway. Immunology 49:685-691, 1983
 
4) Iwaki M, et al:FUT-175 (メシル酸ナファモスタット) の薬理学的作用.Japan J Pharmacol 41:155-162, 1986
 
5) Aoyama T, et al:FUT-175,メシル酸ナファモスタットの薬理的研究1. in vivo及びin vitro実験でのプロテアーゼ活性の阻害.Japan J Pharmacol 35:203-227, 1984
 
6) Uchiba M, et al:DIC:Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation. Elsevier Science Publishers B, V., Amsterdam, p243-251, 1993
 
7) 越山良子ほか:FUT-175 (nafamstat mesilate) の薬理学的研究IV. 血液凝固系,血小板,線溶系に対する作用.目薬理誌84:417-428, 1984
 
8) 澁谷正興ほか:FUT-175 (nafamstat mesilate) の生体内動態に関する研究 (第4報)-ラットおよびイヌにおける代謝物-.基礎と臨床18:4023-4035, 1984
 
9) 安部 英ほか:FUT-175の臨床第一相試験-単一用量および多重用量試験-.薬理と治療12:4941-4964, 1984
 
10) 森河 浄ほか:蛋白分解酵素阻害剤FUT-175の血液透析への応用.人工臓器12:75-78, 1983
 
11) 児島弘臣ほか:短時間作用性透析用抗凝固薬の評価凝固時間測定法の問題点.日本透析療法学会言吉21:621-627, 1988
 
12) 秋沢忠男ほか:血液透析における透析用抗凝固薬 FUT-175およびその代謝物の動態.腎と透析 26:947-953, 1989
 
13) 高岡哲郎:重症感染症と蛋白分解酵素阻害剤. Current Therapy 5:703-707, 1987
 
14) 松澤 史ほか:LDL吸着療法とアナフィラキシー症状-臨床像の特徴と抗凝固剤選択の重要性.人工臓器23:533-536, 1994
 
15) 真辺忠男ほか:特集膵炎の薬物療法-最近の研究から-活性酸素消去剤による急性膵炎の治療.胆と膵12:251-254, 1991
 
16) Sugita H, et al:FUT-175 inhibits the production of IL-6 and IL-8 in human monocytes. Res Commun Mol Pathol Pharmacol 103:57-64, 1999
PubMed
17) Toshiaki S, et al:A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium. Br J Pharmacol 138:959-967, 2003
 
18) 岩垣博巳ほか:Toll-like receptor-4 とprotease inhibitoro. Surgery Frontier 12:202-208, 2005
 
19) 都築英之ほか:特集フサンの多彩な薬理作用を探る[5]NF-κBの制御.医薬の門43:162-167, 2003
 
20) 岩坂日出男:敗血症の新規メディエータHMGB1 とその制御.Surgery Frontier 11:217-222, 2004
Medical*Online
21) 程原佳子ほか:TAP凝集に対する蛋白分解酵素阻害剤の抑制作用について.血管と脈管18:518-527, 1987
 
22) 松田兼一ほか:連載 CHDFの原理と実際 CHDFの原理と施行方法4抗凝固剤.集中治療 9:215-220, 1997
 
23) 平澤博之:特集緊急血液浄化法緊急血液浄化法と健康保険.救急医学17:225-227, 1993
 
P.389 掲載の参考文献
1) Altermatt S, et al:Operative Treatment of Solitaly Bone Cysts with Tricalcium Phosphate Ceramics, A 1 to 7 Year Follow-up. Eur J Pediatr Surg 2:180-182, 1992
 
2) 鳥山素弘ほか:湿式粉砕法を用いたβ-リン酸三カルシウムの合成.窯協誌94:1004-1008, 1986
 
3) Saito M, et al:The role of β-tricalcium phosphate in vascularized periosteum. J Orthop Sci 5:275-282, 2000
 
4) Chazono M, et al:Bone fomlation and bioresorption after implantation of injectable β-tricalcium phosphate granules-hyaluronate complex in rabbit bone defects. J Biomed Mater Res 70A:542-549, 2004
 
5) Kondo N, et al:Bone formation and resorption of highly purified β-tricalcium phosphate in the rat femoral condyle. Biomaterials 26:5600-5608, 2005
 
6) 小澤正宏:高純度β-TCPの骨形成能と溶解性に関する実験的研究.生体材料13:167-175, 1995
 
7) 茶薗昌明ほか:β-リン酸三カルシウム (β一TCP) 移植後の骨形成過程に関する組織学的検討.別冊整形外科47:137-143, 2005
 
8) 小澤正宏ほか:高純度β-TCPの使用経験,167 例の検討.東日本整災会誌12:409-413, 2000
 
9) 平田正純ほか:良性骨腫瘍掻爬後骨欠損に対する補填材としてのβ-TCPの有用性, HAとの比較検討.Orthopaedic Ceramic Implant 21:99-101, 2001
 
10) Ogose A, et al:Comparison of Hydroxyapatite and Beta Tricalcium Phosphate as Bone Substitute After Excision of Bone Tumors. J Biomed Mater Res 72B:94-101, 2005
 
11) Jingushi S, et al:Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with beta-tricalcium phosphate as a carrier;in vivo bone banking for muscle-pedicle autograft. J Orthop Sci 7:490-494, 2002
PubMed
12) Dong J, et al:Promotion of bone formation using highly pure β-TCP combined with bone marrow-derived osteoprogenitor cells. Biomaterials 23:4493-4502, 2002
 
13) 伊藤邦臣ほか:整形外科領域におけるAPS-7の臨床評価に関する研究.基礎と臨床21:749-765, 1991
 
14) 国分正一ほか:Hydroxyapatite棘突起spacerを用いた黒川式棘突起縦割法頚椎脊柱管拡大術.日本脊椎外科学会誌2:233, 1991
 
15) 浜田良機:腫瘍性疾患に対するセラミックスの長期成績.関節外科14 (11):17-24, 1995
 
16) 鎌田修博ほか:脊椎悪性腫瘍に対するハイドロキシアパタイトを用いた人工椎体置換術の成績.整形外科44:55-60, 1993
 
17) Oonishi H, et al:Degradation/resorption in bioactive ceramics in orthopaedics. Chapter 8, J BIack and G Hastings ed:Hand book of Biomaterial Properties First edition, Chapman& Hall, p406-419, 1998.
 
18) 大西啓靖ほか:現代医療の最前線 (人工関節はここまで進歩している).最新医学58:1400-1424, 2003
 
19) 大西啓靖ほか:超長期耐用しうる人工関節の固着法-界面バイオアクティブ骨セメント法-.骨関節靭帯18:9-16, 2005
 
P.396 掲載の参考文献
1) 七里元亮ほか:ベッドサイド型人工人工膵島の開発と臨床応用-治療機器およびResearch Toolとしての有用性-.現代医療14:1951, 1982
 
2) 河盛隆造ほか:過酸化水素電極を用いたGlucose Sensorの開発.医用電子と生体工学18:420, 1980
 
3) 河盛隆造ほか:人膵β細胞による膵摘糖尿病犬の血糖制御.医用電子と生体工学16:81, 1978
 
4) 七里元亮ほか:ブドウ糖注入プログラムを付加した人工膵島の開発.糖尿病 23:47, 1980
 
5) 荒木栄一ほか:人工膵臓の現況.糖尿病45:12, 2002
 
6) Van der Berghe G, et al:Intensive insulin therapy in critically ill patients. N Engl J Med 345 (19):1359, 2001
 

書評

最近チェックした商品履歴

Loading...